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Abstract
Due to increasing rates of obesity and its comorbidities, there is tremendous interest in the central
nervous system (CNS) control of energy balance. This basic science interest is guided in part by the need
to develop effective drugs for the overweight and the obese patient. Despite a large literature, our
understanding of the circuits and neurochemical receptors that mediate energy balance is still limited.
The studies described here address this limitation by defining neural circuits that mediate melanocortin´s
effects on energy balance. Disruption in CNS melanocortin receptor (MCR) signaling is the single largest
monogenic cause of human obesity and also produces severe hyperphagia and reduced energy
expenditure in rodents. Forebrain ventricular application of MCR agonists, triggers sympathetically
mediated expenditure responses that have been attributed to signaling at hypothalamic structures.
However, caudal flow of the injected ligands in CSF makes them available to extrahypothalamic sites.
Given the widespread distribution of MCRs it is impossible to define which MCR-bearing neurons - among
them several hypothalamic and hindbrain nuclei- contribute to the observed effects. Here we
characterized the respective contributions of the hypothalamic and caudal hindbrain MCRs to energetic
and intake control with ventricular (3rd and 4th v) as well as selective parnechymal MCR agonist delivery.
Results demonstrate that thermogenic, cardiovascular and anorexic responses of similar size and
duration can be obtained by stimulation of several hypothalamic and hindbrain MCR populations. Using
an antagonist treatment we evaluated the endogenous hindbrain MCR contributions to the intake and
thermogenic responses driven by leptin (a hormone produced by the adipose tissue) and an exposure to
palatable, high-energy diet. Results indicated that hindbrain MCRs are required for mediation of anorexic
and thermogenic effects of hindbrain leptin and for limiting overeating induced by palatable high-energy
diet. The data presented here confirm the hypothesis that the melanocortin system’s contribution to food
intake and energy expenditure is distributed across spatially distinct regions of the brain. Taken together
results demonstrate the presence of an independent hindbrain MCR-driven energy balance circuitry that
responds to peripheral inputs (e.g. leptin) and physiological challenges (e.g. high-energy diet) similarly to
what has been earlier ascribed to the hypothalamic MCR populations.
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ABSTRACT
ENERGY BALANCE EFFECTS OF CENTRAL MELANOCORTIN,
COCAINE AND AMPHETAMINE RELATED TRANSCRIPT AND
LEPTIN: MOVING OUTSIDE OF THE HYPOTHALAMIC BOX.
KAROLINA PATRYCJA SKIBICKA
ADVISOR: HARVEY J GRILL

Due to increasing rates of obesity and its comorbidities, there is tremendous
interest in the central nervous system (CNS) control of energy balance. This basic
science interest is guided in part by the need to develop effective drugs for the
overweight and the obese patient. Despite a large literature, our understanding of the
circuits and neurochemical receptors that mediate energy balance is still limited. The
studies described here address this limitation by defining neural circuits that mediate
melanocortin´s effects on energy balance. Disruption in CNS melanocortin receptor
(MCR) signaling is the single largest monogenic cause of human obesity and also
produces severe hyperphagia and reduced energy expenditure in rodents. Forebrain
ventricular application of MCR agonists, triggers sympathetically mediated expenditure
responses that have been attributed to signaling at hypothalamic structures. However,
caudal flow of the injected ligands in CSF makes them available to extrahypothalamic
sites. Given the widespread distribution of MCRs it is impossible to define which MCRbearing neurons - among them several hypothalamic and hindbrain nuclei- contribute
to the observed effects. Here we characterized the respective contributions of the
hypothalamic and caudal hindbrain MCRs to energetic and intake control with
ventricular (3rd and 4th v) as well as selective parnechymal MCR agonist delivery. Results
demonstrate that thermogenic, cardiovascular and anorexic responses of similar size
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and duration can be obtained by stimulation of several hypothalamic and hindbrain
MCR populations. Using an antagonist treatment we evaluated the endogenous
hindbrain MCR contributions to the intake and thermogenic responses driven by leptin
(a hormone produced by the adipose tissue) and an exposure to palatable, high-energy
diet. Results indicated that hindbrain MCRs are required for mediation of anorexic and
thermogenic effects of hindbrain leptin and for limiting overeating induced by palatable
high-energy diet. The data presented here confirm the hypothesis that the melanocortin
system’s contribution to food intake and energy expenditure is distributed across
spatially distinct regions of the brain. Taken together results demonstrate the presence
of an independent hindbrain MCR-driven energy balance circuitry that responds to
peripheral inputs (e.g. leptin) and physiological challenges (e.g. high-energy diet)
similarly to what has been earlier ascribed to the hypothalamic MCR populations.
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CHAPTER 1: GENERAL INTRODUCTION

I. Energy Balance Control
According to the center for disease control, about 65% of Americans are either
overweight or obese (Hedley et al., 2004). In the last decade obesity and comorbid
pathologies including type 2 diabetes, hypertension, and cardiovascular disease have
been dramatically increasing, becoming a great burden not only on the health care
system but also on economy. The desire to prevent these pathologies has sparked an
interest in defining the mechanisms of neural control of energy balance. Energy balance
is achieved through the coordinated control of two systems, one controlling energy
intake (feeding) and the other energy expenditure (limitation or facilitation of the use of
available energy resources). Changes in feeding patterns have been most commonly
linked to increases in body weight. Increases in the consumption of fats (particularly
saturated fats), and simple carbohydrates, have contributed to the increases in the
prevalence of obesity. Chronic overconsumption of calorically dense meals causes a
disruption in homeostatic mechanisms of body weight control, often progressively
leading to an allostatic level of energy balance that defends the increased body weight
even after the intake has been reduced. This ‘hard-wired’ defense of body weight has
been attributed to the ineffectiveness of many weight reduction diets. This brings
attention to the second essential component of energy balance: energy expenditure (EE).
Reduction in EE also contributes to the obesity epidemic. Therefore treatments
targeting both energy intake and EE will be more effective then dieting alone. Clearly
more attention needs to be focused on the EE side of the energy balance equation.
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EE in mammals can be divided in to three main components: basal metabolism,
adaptive thermogenesis and non-resting energy expenditure (physical activity).
Adaptive thermogenesis is a response induced by challenging environmental stimuli
such as cold, food consumption and pathogenic stimuli including infection and stress
(Dulloo, 2002; Dulloo et al., 2004). Thermogenic responses are tuned to these different
environmental stimuli. Relevant environmental and internal stimuli are processed and
integrated, at a number of CNS sites and if need arises, thermogenic effectors are
stimulated via the sympathetic nervous system (SNS). A number of sympathetic premotor nuclei drive thermogenic effectors. SNS control of brown adipose tissue (BAT)
has the largest thermogenic capacity in rodents (Cannon and Nedergaard, 2004).
Various peptide systems contribute to both sides of energy balance control. The
major contributors can be organized into two classes: anabolic and catabolic. On the
catabolic side, central melanocortin system and leptin are of fundamental importance.
In addition, cocaine and amphetamine related peptide (CART) has recently emerged as
a potential counterpart of melanocortin in the energy balance effects. The work in this
dissertation concerns the contribution of all three peptides to the control of feeding
behavior and various aspects of energy expenditure.

II. Central Melanocortin System

a. General
Exogenous stimulation of the melanocortin system decreases food intake and increases
EE; it is therefore, a potential target for treatment of obesity. While the melanocortin
influence on feeding is under extensive scrutiny, much less is known about the
melanocortin circuitry contributing to EE. The principal goals of the work proposed
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below are to elucidate the central melanocortin circuits that contribute to EE control, to
distinguish potentially separate contributions of melanocortin receptors (MCRs) in
hypothalamus/forebrain and caudal brainstem, and to distinguish their engagement
under different physiological conditions.

The central melanocortin system is unique since it is composed of not only neurons
that produce the endogenous agonists for MC3R and MC4R, the two central receptors,
but also of neurons that produce an endogenous antagonist (Cone, 2005). The
endogenous agonists, α-MSH, β-MSH and γ-MSH, are products of the
proopiomelanocortin (POMC) gene neurons which are located only in two regions of the
brain: hypothalamic arcuate nucleus (ARC), and the nucleus of the solitary tract (NTS)
within the caudal brainstem. Neurons producing the antagonist (AgRP) are present in
the ARC (Broberger et al., 1998; Bagnol et al., 1999; Haskell-Luevano et al., 1999). The
MC4Rs on the other hand, are widely distributed across the neuraxis, from the forebrain
to the caudal brainstem (Mountjoy et al., 1994; Kishi et al., 2003). MC3R mRNA is
much less distributed than MC4R, with most abundant expression sites in hypothalamic
areas participating in thermogenesis and cardiovascular function. High MC3R
expression has been identified in the ARC on POMC positive neurons and on terminal
fields of these neurons, suggesting a possible role of MC3R as an autoreceptor in this
area (Roselli-Rehfuss et al., 1993; Marks et al., 2006). None of the MC3R positive cells
were found in the caudal brainstem regions such as NTS, pointing to diversity of MCR
expression among different levels of the melanocortin system (Roselli-Rehfuss et al.,
1993).
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b. Food intake
The central melanocortin system is already recognized as an important contributor to
feeding control in the mammalian energy balance equation. Disruption in CNS
melanocortin activity is the single largest monogenic cause of human obesity.
Polymorphisms and mutations of POMC gene as well as mutations of MC4R receptor
have been linked to human obesity (Comuzzie et al., 1997; Krude et al., 1998; Hinney et
al., 1999; Hixson et al., 1999). Similarly a deletion of MC4R or POMC gene, or
overexpression of AgRP in mice, causes a pronounced obese phenotype (Klebig et al.,
1995; Huszar et al., 1997; Wolff et al., 1999; Yaswen et al., 1999). Most pharmacological
studies to date have focused on the intake effects of melanocortins. MC agonist and
antagonist, administered directly into the rodent brain, cause a large decrease and a
large long lasting increase in food intake respectively. However, an alteration in food
intake following a disruption of melanocortin signaling is not the only factor
contributing to obesity. MC4R KO mice for example have significantly altered EE,
independent of the food intake effects, with 20% decrease in resting EE as measured by
oxygen consumption, compared to weight matched controls (Ste Marie et al., 2000).

For the energy balance field many functions are localized to hypothalamic neurons
and circuits. This is certainly true for the analysis of feeding control. Also for EE,
research has focused on the sensory, integrative and motor output control mechanisms
seated within hypothalamic nuclei and related forebrain structures. Unfortunately this
focus has neglected potentially, and in some cases demonstrably, critical contributions
of extrahypothalamic structures particularly those in caudal brainstem structures. For
feeding function, the contribution of the caudal brainstem melanocortin system is
highlighted in previous work of our laboratory. Emphasis on distributed control was
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provided by the demonstration that local stimulation of MCRs in anatomically distinct
regions (lateral and 4th ventricle injections) gives rise to an anorexic response (to
melanocortin agonists) and orexigenic response (to antagonists) (Grill et al., 1998). The
case was strengthened by the demonstration that the same response was obtained with
parenchymal injections in the dorsal medulla at doses well below threshold for the
ventricular effect (Williams et al., 2000a). This is not to discount the forebrain
contribution. Indeed responses from the third ventricle were observed even when the
caudal flow of CSF was blocked with a cerebral aqueduct plug [unpublished
observations, for method see (Faulconbridge et al., 2005)]. Here we will apply a similar
strategy to explore the melanocortin contribution to EE.

c. Thermoregulation
Anatomical analysis of CNS networks controlling SNS outflow to BAT, with
pseudorabies virus injections into the intercapsular BAT, show convergence of the
retrogradely labeled structures and known distribution of MC4Rs and MC neuron
projections. As expected from literature on hypothalamic involvement in energy
balance, BAT projections were traced with transsynaptically transported label to many
hypothalamic sites including medial preoptic area of the hypothalamus (MPOA), as well
as ventromedial and dorsomedial hypothalamus (Bamshad et al., 1999; Oldfield et al.,
2002; Morrison, 2004). Importantly, all of the labeled hypothalamic nuclei receive
melanocortin projections and express MCR (Jacobowitz and O'Donohue, 1978; Palkovits
et al., 1987; Joseph and Michael, 1988; Sim and Joseph, 1994; Fan et al., 2005; VossAndreae et al., 2007). However the overlapping melanocortin projections with BAT
retrograde tracing were also found in extrahypothalamic sites, particularly in caudal
brainstem nuclei including: parabrachial nucleus (PBN) and raphe pallidus (RP), with
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many BAT and melanocortin projections converging at the intermediolateral column,
the site of BAT preganglionic sympathetic neurons (Voss-Andreae et al., 2007). In
addition, BAT projections could also be traced to ARC and NTS, the only two CNS sites
containing POMC neurons (Voss-Andreae et al., 2007). Such points of overlap may
suggest that both hypothalamic and caudal brainstem divisions of the MC system may
modulate BAT activity. A level of complexity is added by the interaction between the
brainstem and hypothalamic melanocortin neuron signaling, made possible by the dual
innervation of given structures (including NTS, PBN, ARC, PVN) by both POMC neuron
centers [for review see (Fan et al., 2007)].
Pharmacological stimulation of central MCRs, with MTII (selective for MC3R and
MC4R), in rats and wild type mice increases oxygen consumption (Fan et al., 1997;
Zhang et al., 2004). Hypothalamic MCR stimulation via MTII injections to third
ventricle of free feeding rats during the dark cycle increase EE as reflected in increases
in core temperature (Murphy et al., 2000). MTII administration to the 3rd ventricle also
dose-dependently increased sympathoexcitation to BAT, the effect was abolished by
coadministration of MC3R/4R antagonist (SHU 9119) (Haynes et al., 1999). Chronic
AgRP (MC3R/4R antagonist) infusion to the third ventricle decreases BAT UCP-1
(uncoupling protein associated with increased thermogenesis in BAT) expression
independent of its orexigenic effects (Small et al., 2003). Much less is known about
caudal brainstem MCR-mediated control of BAT thermogenesis. Forebrain but also
caudal brainstem MCR stimulation via semi-chronic (3 injections over 36 hours) MTII
administration to third and fourth ventricles leads to increased UCP-1 expression, which
was shown to be dependent on sympathetic mediation as the denervation of BAT
abolished the response (Williams et al., 2003). Taken together, pharmacological
stimulation experiments suggest that both caudal brainstem and hypothalamic MCRs
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have the potential to drive sympathetically mediated BAT-dependent thermogenic
response. Therefore we will give both receptor populations equal attention while
examining the hypothesis that anatomically distributed MCR expressing regions
contributes to activation of thermogenic responses.

d. Cardiovascular regulation
Anatomical and pharmacological evidence points to a prominent role of
melanocortins in cardiovascular function. Patients with dysfunctional MCRs have lower
blood pressure and heart rate compared to weight matched controls, despite their
obesity (Greenfield et al., 2009). Both parameters are also increased when MCR agonist
is given to normal subjects (Greenfield et al., 2009). Central MCR agonist application
produces profound and long lasting increases in blood pressure and heart rate in rats (D
Ramaekers, 2002). Those effects are mediated by SNS excitation of the heart (Kuo et al.,
2004). Conversely, blockade of central MCRs decreases both blood pressure and heart
rate (Kuo et al., 2003). Both effects are independent of the feeding effects of
melanocortins as they persist in pair fed rats (Kuo et al., 2003). The dissociation of the
feeding and cardiovascular effects of MCR stimulation is further strengthened by the
fact that obesity induced by high fat feeding attenuates the anorexic effect of MCR
agonist, however the tachycardic effects persist (Silva et al., 2006). This dissociation is
of critical importance as it suggests that MCR signaling underlies the hypertension and
tachycadia observed in obese patients (without MCR mutations). Despite the broad
distribution of MCRs in areas associated with cardiovascular control the literature has
ascribed the action of central (lateral or 3rd ventricular) MCR agonist and antagonist
application to activation of MCRs in hypothalamic nuclei (Kuo et al., 2003). In fact,
ventricular drug application potentially allows for stimulation of not only the
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hypothalamic MCRs but also the hindbrain MCRs, as the drug flows caudally with CSF.
Thus, it is not at all clear which of the MCR expressing nuclei contribute to the
ventricular effect. The specific role of hindbrain MCR in those effects remained largely
unexplored. Therefore here we specifically address the role of hindbrain MCRs in the
cardiovascular regulation.

e. Physical activity
A decrease in spontaneous locomotor activity can be a contributing factor to the
pathogenesis of obesity and fat pad deposition (Castaneda et al., 2005). While little is
known about the neural basis of this response, available evidence implicates many of the
neuropeptides associated with food intake in the control of physical activity. Central
(ventricular) MTII stimulation increases and endogenous antagonist – AgRP application
decreases spontaneous locomotor activity in rats (Hwa et al., 2001; Tang-Christensen et
al., 2004; Koo et al., 2008). Similarly, as for the thermic and cardiovascular effects of
melanocortins, the neuroanatomical substrate of this MCR function is unclear. Our
studies will therefore evaluate the role of hindbrain, as well as several
forebrain/hypothalamic MCR-expressing nuclei in physical activity control.

III. Central Effects of Leptin
Leptin, a circulating hormone produced by the white adipose tissue, like
melanocortin, is anorexic and thermogenic when applied centrally (Scarpace et al., 1997;
van Dijk et al., 1999; Rahmouni et al., 2002). POMC neurons and MCRs are an
important downstream mediator of the energy balance effects of basal forebraindirected, third ventricular (3rd v) leptin delivery (Seeley et al., 1997; Satoh et al., 1998;
Haynes et al., 1999). This perspective is supported by experiments that show that: leptin
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signaling in these neurons increases POMC gene expression (Schwartz et al., 1997;
Elmquist, 2001) and pretreatment with MCR antagonist attenuates the anorexic effects
as well as some of the SNS- mediated energetic effects of 3rd v leptin delivery (Seeley et
al., 1997; Haynes et al., 1999). Similarly, as described above for the melanocortin system,
the central actions of leptin have been ascribed to the hypothalamic leptin receptor
(ObRb) populations, without much attention given to the two hindbrain ObRb
expressing nuclei (NTS, PBN). While evidence exists that part of the anorexia induced
by leptin is mediated by NTS ObRb (Huo et al., 2007), the energetic effects of selective
hindbrain ObRb stimulation have not been examined. Here we examine a role of
hindbrain ObRb stimulation in the thermoregulation, cardiovascular functions and
activity regulation and evaluate whether hindbrain MCRs contribute to the energy
balance effects triggered by selective hindbrain leptin stimulation.

IV. Cocaine and amphetamine regulated transcript
In arcuate hypothalamic neurons CART is co-expressed with POMC. Increase in
melanocortin signaling produces hypophagia, hyperglycemia, hyperthermia, tachycardia
and increased activity (Fan et al., 2000; Gutierrez-Juarez et al., 2004; Skibicka and Grill,
2008a). Leptin upregulates and food deprivation downregulates hypothalamic
expression of POMC as well as CART (Kristensen et al., 1998). These functional changes
and the co-expression of CART with POMC, led to the suggestion that CART peptides
have a catabolic function – with treatment producing reductions in food intake and
increases in energy expenditure. The fact that 3rd and 4th v CART injection produces
anorexia and arcuate and paraventricular nucleus CART delivery increases UCP-1
expression in interscapular brown adipose tissue is consistent with that notion (Wang et
al., 2000; Kong et al., 2003). However, the EE effects of CART have been insufficiently
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investigated, as those investigations have not gone beyond measuring UCP-1, which is a
useful correlate of BAT activity, although not an accurate measurement of BAT
thermogenesis. Here we investigate whether the EE function of CART parallels that of
melanocortin at both the hindbrain and forebrain level of the neuraxis.

V. Hindbrain competence (Chronic decerebrate preparation)

We may demonstrate effects of MCR agonist and antagonist in hindbrain on
thermogenesis. Such results, as argued, would stand alongside similar demonstrations
for isolated stimulation of forebrain structures, making part of the case for anatomically
distributed controls for thermogenesis most generally, and specifically for the
melanocortin contribution. These outcomes, however, would not speak to the
integrative substrates downstream of the MCRs that may be critical for expression and
coordination of thermogenic responses. The hindbrain may contain receptor “triggers”
for responses, but the hypothalamus may perform essential operations entailing both
ascending and descending pathways. The sufficiency of the hindbrain substrates for
mediation of responses observed in the whole animal is addressed below in proposed
experiments with the utility of the chronic decerebrate (CD) rat preparation. Our
laboratory has developed this preparation over many years, and applied it successfully
to evaluate the integrative potential of the hindbrain. This work has focused on the
control of ingestive behavior and to a lesser extent, endocrine function. It has been
shown, for example, that the CD behaves as its neurologically intact control with respect
to discriminative response to gustatory stimulation and modulation of meal size by such
prototypical treatment as nutrient preloads, sham feeding, food deprivation and
systemic administration of CCK and central administration of anorexic agents such as
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urocortin-1 [for review see (Grill and Norgren, 1978; Grill and Kaplan, 2002). For
feeding function, it can be concluded (from the intact like function in CD) that despite
the many deficits of the CD rat (e.g. blindness, anosmia) complete circuits, from
sensory inputs to integrative processing and effector commend, are contained within the
hindbrain. We propose to determine whether a similar judgment can be derived with
respect to thermoregulatory control. At some level, the feeding related work offers some
encouragement, because of the coordinated control of effectors on both sides of energy
balance; and because many of the same structures in the brainstem are implicated in the
control of sympathetic outflow to thermogenic effectors (e.g. NTS, PBN, VLM) are also
critical players in control of ingestive behaviors. The story that emerges from the
proposed work, however, may not conform to principles of parsimony. A failure of the
CD to display normal like responses would point to critical contributions of forebrain
substrates, or at least to necessary neural communication that will add to our
appreciation of the neuroanatomically distributed system for the control of EE.

VI. Overview of dissertation

The previous literature clearly establishes that administration of melanocortin to
forebrain ventricles or directly to the hypothalamic nuclei results in decreased food
intake and increased EE but the location of MCRs relevant to these responses had not
been throughly explored. Given the presence of MCR in the hindbrain, we hypothesized
that the thermogenic, tachycardic and activity responses to melanocortin may be
triggered independently by MCR stimulation in the forebrain and separately in the
hindbran. Our hypothesis is strenghtened by previous work clearly showing a forebrain
independent, hindbrain trigger for MCR stimulation induced hypophagia. In Chapter 2
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we find support for this hypothesis by showing that selective hindbrain MCR
stimulation produces a pronounced and long-lasting hyperthermia for the BAT and
body core, as well as tachycardia and hypophagia. To establish the independence of the
neurociruitry mediating those obtained responses we evaluate them in a CD model.
Obtaining similar responses in a CD rat as those seen in an intact rat would indicate that
the circuitry downstream of the MCR stimulation required for the production of an
energetic effect is endemic to the hindbrain. Subsequently we deliver melanocortin
agonist (MTII) directly to the hindbrain parenchyma (caudal raphe) at doses below the
threshold for the ventricles and obtain feeding and energetic responses, affirming a role
for the hindbrain in the energy balance effects of exogenous MCR stimulation.

While Chapter 2 shall provide solid support for a hindbrain site of MCR action, it
would not specify which of the several MCR expressing populations within the
hindbrain underlie the responses obtained with fourth ventricular stimulation.
Considering that several hindbrain MCR expressing nuclei (NTS, RVLM, and PBN) have
well established connections to sympathetic and feeding behavior output we hypothesize
that all of them contribute to MCR energy balance effects. We also predict that a similar
range of energy balance effects could be obtained with MCR stimulation in the
hypothalamic nuclei (PVN, RCh), as they are too well connected to the relevant output
systems. We evaluate those predictions in Chapter 3 where we provide selective MCR
stimulation to each of those nuclei and measure food intake, core temperature, heart
rate and activity. If our predictions are correct we would have shown that
melanocortinergic control of various parameters of energy balance is beyond doubt
distributed across the whole neuraxis.
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In Chapter 4 we begin to evaluate the peripheral inputs to the hindbrain
melanocortin system. That a peripheral adipostat hormone, leptin, activates the
hypothalamic melanocortin producing neurons and MCRs is well established. We
examine whether a similar relationship exists for hindbrain selective leptin application.
We first establish that hindbrain effects of leptin on energy expenditure are comparable
to those obtained with hypothalamic/forebrain application. Next, we evaluate the effects
of selective hindbrain MCR blockade on the hindbrain thermogenic, tachycardic and
anorexic effects of leptin.

In Chapter 5 we continue the evaluation of peripheral inputs that require
downstream hindbrain MCR activation. In Chapter 4 we assessed the hindbrain specific
leptin-MCR interaction. Here we examine an interaction of hindbrain MCRs with the
endogenous input emerging from high-fat feeding on food intake and energy
expenditure. The studies reported here are the first to identify a contribution of
endogenous activity at hindbrain MCRs to thermoregulation and cardiovascular
function.

In Chapter 6, a similar strategy to that assessing hindbrain MCR effects is
applied to examine the intake, blood glucose regulation, core temperature, heart rate
and activity effects of hindbrain CART peptide application. In spite of the close
association in the literature of CART with melanocortins and its assumed catabolic
function, a surprising opposing effect of CART on temperature is obtained – a
pronounced and long lasting hypothermia. Subsequently the neurocircuitry underlying
this unexpected effect is characterized, to show that, unlike melanocortinergic
hyperthermia, the CART hypothermia is mediated by forebrain processing and that both
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the anorexia and hypothermia of hindbrain CART are mediated by hindbrain glucagonlike-peptide-1 receptors.

A general discussion of the results obtained across experiments is presented in
Chapter 7.
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CHAPTER 2.
ENERGETIC RESPONSES ARE TRIGGERED BY CAUDAL BRAINSTEM
MELANOCORTIN RECEPTOR STIMULATION AND MEDIATED BY
LOCAL SYMPATHETIC EFFECTOR CIRCUITS1

ABSTRACT
The central melanocortin system is a critical contributor to energy balance control.
Melanocortin receptors (MC-Rs) are widely distributed throughout forebrain and caudal
brainstem nuclei. In order to assess the contribution of hindbrain MC-Rs to the control
of energy expenditure, the MC3/4R agonist MTII was delivered to either the 4th ventricle
or medullary raphe of neurologically intact rats and chronic decerebrate rats and
interscapular brown adipose tissue (IBAT) temperature (TIBAT), core temperature (TC),
heart rate (HR) and spontaneous activity were recorded. Fourth ventricular MTII (0.1,
1.0 nmol) significantly increased TIBAT, TC and HR in intact rats (TC: +0.33 ± 0.08, +0.41
± 0.09 oC; HR: +40.84 ± 7.29, +69.04 ± 6.83 BPM) and in chronic decerebrates (TC:
+1.39 ± 0.67, +1.52 ± 0.37 oC; HR: +83.21 ± 19.2, +107.38 ± 17.65 BPM). Response
magnitude was greater in chronic decerebrate rats than in neurologically intact rats.
TIBAT, TC and HR were significantly increased after 10 pmol MTII delivery to the
medullary raphe of intact rats, and here too, the response magnitude was greater in
decerebrate rats. The hyperthermia, IBAT thermogenesis, and tachycardia observed in
chronic decerebrate rats following 4th ventricular and hindbrain parenchymal MTII
injections supports the hypothesis that hindbrain MC-R stimulation engages endemic
circuits that link sympathetic outflows to thermogenic and cardiac effectors and that
1

These results were partially reported at the 2006 North American Association for the Study of Obesity
Annual Meeting, in Boston MA, and appeared in Endocrinology, 149(7):3605-16, 2008. This work was
supported by Systems and Integrative Biology and Behavioral Neuroscience Training Grants, and NIH
grant DK-21397.
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forebrain processing and forebrain-caudal brainstem communication is not required for
response production.
INTRODUCTION
Melanocortin ligands and receptors are an essential component of the central nervous
system (CNS) control of energy balance. Mutations of the genes for the melanocortin 4
receptor (MC4-R) or the ligand precursor, pro-opiomelanocortin (POMC) are associated
with severe obesity in humans (Yeo et al., 1998; Krude et al., 2003; Dubern et al., 2007).
In rodent models, agonist stimulation (pharmacologic or genetic) of MC4-R potently
reduces food intake and body weight, while antagonism of the MC4-R results in
hyperphagia and obesity (Huszar et al., 1997; Grill et al., 1998; Yaswen et al., 1999).
While MC-R (MC4-R, MC3-R) treatment-induced changes in body weight are typically
ascribed to changes in food intake, other data suggest that MC-R effects on body weight
may also be mediated by alterations in energy expenditure. For example, increased
energy expenditure follows peripheral or forebrain ventricular application of MC-R
agonists (Haynes et al., 1999; Murphy et al., 2000; Nordheim et al., 2006), while
reduced expenditure results from MC-R antagonist treatment or targeted deletion of the
MC4-R (Ste Marie et al., 2000; Voss-Andreae et al., 2007). Despite a wide anatomical
distribution of MC4-R (Kishi et al., 2003), the field has emphasized hypothalamic
contributions to MC4-R mediated energetic effects [e.g. (Harrold et al., 1999; Williams
et al., 2000b)] but has not thoroughly characterized the contribution of extrahypothalamic MC4-Rs or the downstream neural circuitry mediating MC4-R-induced
energy balance effects.

This paper addresses whether MC-R bearing neurons in the caudal brainstem
contribute to energy expenditure responses and whether the sympathetic output circuits

16

mediating the energetic effects involve processing by both caudal brainstem and
forebrain structures. A useful strategy for highlighting the candidate MC-R bearing
neurons comes from studies that examine MC4-R expression in the sympathetic premotor neurons controlling interscapular brown adipose tissue (IBAT) temperature.
Notable among the identified neurons are the MC4-R expressing neurons in the
hypothalamic paraventricular nucleus (PVN), the dorsomedial hypothalamic nucleus
(DMH) and lateral hypothalamic area (LH) that are retrogradely labeled with
pseudorabies-virus injections into IBAT, a key thermogenic effector in rodents (Cano et
al., 2003a; Voss-Andreae et al., 2007). While MC-R bearing hypothalamic neurons,
especially those of the PVN, provide a focus for many studies addressing the mediation
of MC-R effects on energy expenditure (Harrold et al., 1999; Williams et al., 2000b),
MC4-Rs are also expressed extra-hypothalamically in several caudal brainstem nuclei
that are linked to the control of IBAT and cardiac responses. Caudal brainstem neurons,
including those of the nucleus tractus solitarius (NTS), medullary raphe (raphe pallidus
[RPa], raphe obscurus, raphe magnus), parabrachial nucleus, and rostroventrolateral
medulla (RVLM) express MC4-R and are retrogradely labeled by IBAT pseudorabies
virus injection (Voss-Andreae et al., 2007). A critical role for RPa neurons in the control
of IBAT thermogenesis, heart rate and sympathetic outflows is well established (Rathner
et al., 2001; Blessing, 2003; Cao and Morrison, 2003; Morrison, 2003; Horiuchi et al.,
2004; Morrison, 2004; McAllen et al., 2006; Fan et al., 2007). Neurons expressing
MC4-R in the RPa and RVLM are also associated with cardiovascular efferent control by
other investigators (Coleman and Dampney, 1995; Samuels et al., 2002; Mountjoy et al.,
2003).
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To examine the contribution of MC-R-bearing caudal brainstem neurons to
energy expenditure control and to determine whether processing endemic to the
hindbrain (in the absence of forebrain processing) is required for MC-R mediated
autonomic response production, MC-R agonist-induced energetic responses of
neurologically intact rats were compared to those of rats whose caudal brainstem was
neurally isolated from the forebrain via complete supracollicular transection. IBAT
temperature, core temperature, heart rate, and spontaneous activity were monitored in
response to hindbrain (4th) ventricular, medullary raphe parenchymal and systemic (i.p.)
injection of melanotan II (MTII), a ligand of the MC4-R and MC3-R. Results establish a
role for the hindbrain MC-Rs in the control of energy expenditure and show that
endemic caudal brainstem circuits are sufficient for hindbrain-generated response
production and that hypothalamic processing and hypothalamic-forebrain
communication is not necessary.

METHODS

Subjects

Male Sprague-Dawley rats (Charles River Laboratories, Wilmington, MA), weighing
300–400 g at the time of surgery and housed individually in plastic bins under a 12:12-h
light-dark cycle (8:00 am lights on), participated in the five experiments described
below. Pelleted food (Purina 5001; St. Louis, MO) and water were available ad libitum
unless otherwise noted. All procedures conformed to the institutional standards of
animal care and use (University of Pennsylvania).

Surgery
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Rats were anesthetized with ketamine (90 mg/kg), xylazine (2.7 mg/kg), and
acepromazine (0.64 mg/kg) delivered intramuscularly.

4th intracerebroventricular and medullary raphe cannula. Rats in Experiments 1,3,4,5
and 6 received a fourth-intracerebroventricular (4th i.c.v.) guide cannula (Plastics One,
22-G) with its tip stereotaxically positioned 2.0 mm above the 4th ventricle (coordinates:
on the midline, 2.5 mm anterior to the occipital suture, and 4.5 mm ventral to the dura,
with injector aimed 6.5 mm ventral from dura). Rats in Experiments 4,5 and 6 also
underwent a decerebration surgery. Rats in Experiment 3A received a guide cannula
aimed at the medullary raphe (coordinates: on the midline, 3 mm posterior to lambda,
and 7.4 mm ventral to the dura, with injector aimed 9.4 mm ventral to dura). Medullary
raphe injections for the rats in Experiments 3B and 6 utilized the 4th i.c.v guide cannula
(above) with injectors positioned 5 mm below the guide cannula aimed at the medullary
raphe (injector aimed 9.5 mm ventral to dura). Cannulas were attached to the skull with
dental acrylic and jeweler's screws and closed with an obturator.

Decerebration surgery. Supracollicular decerebration was performed in two hemitransection stages separated by at least 1 wk, as previously described (Grill and Norgren,
1978). Decerebrate rats received 4th i.c.v. cannulas during the second hemisection
surgery. Pair-fed neurologically intact control rats were also anesthetized on two
occasions and implanted with 4th i.c.v. cannulas during the second surgery. Rats
recovered for at least 1 wk before the experiment started. The completeness of the
intended transection was verified histologically after the experiment. Only rats with a
histologically verified complete transection were included in the data analyses.
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Telemetric transponder surgery: Telemetric transponders (HRC 4000 Mini-Mitter,
VitalView, OR) for recording core temperature (Tc), heart rate (HR) and spontaneous
physical activity (SPA) were inserted into the abdominal cavity, with the leads
positioned subcutaneously and secured to the chest muscles on either side of the heart
with sutures. In Experiment 3 animals received a smaller telemetric transponder for
recording IBAT temperature (TIBAT) and SPA (G2, VitalView, OR). The skin overlying the
IBAT pad was opened and the transponder positioned on the right side of IBAT,
avoiding the midline vessels and nerves, and secured with sutures to the overlying
muscle. In Experiments 1, 4 and 6, separate groups of animals were implanted with
IPTT-300 (Bio Medic Data Systems, ID) transponders that measured only the TIBAT.

Experimental procedure

Cannula position verification. At least 7 days after surgery, 4th i.c.v. cannula placement
was assessed by measurement of the sympathoadrenal mediated glycemic response to 5thio-D-glucose [210 µg in 2 µl of artificial cerebral spinal fluid (aCSF)] (Ritter et al.,
1981). A post-injection elevation of at least 100% of baseline plasma glucose level was
required for subject inclusion. The medullary raphe placement was determined
histologically after the experiment with injection of pontamine sky blue at the 100 nL
volume used in the experiments.

Habituation training. Prior to the start of experimental testing, rats were acclimated to
handling and to injections used in a given experiment [4th i.c.v., parenchymal,
intraperitoneal (i.p.)]
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Food intake and body weight monitoring: Food was removed at injection time (early in
the light cycle, between hours 9.30 and 11:00 am) and returned 8 h later, late in the light
phase. Thereby, food was not available during the period of energetic response
measurement. Food intake and body weight measurements were performed 24 h after
the injection of drug. Given this design, all noted differences in food intake reflect longer
latency effects of MTII (from hour 8 to hour 24-post injection). For ad libitum feeding
rats, food was always available during the dark cycle and a minimum of 48 h was
allotted between experimental testing for all animals.

Experiment 1: Effects of stimulating caudal brainstem MC-Rs via 4th i.c.v. MTII
injection on energy expenditure. Neurologically intact rats (n=11) received 4th i.c.v.
injections early in the light cycle. Three conditions were run in a counterbalanced
fashion across separate days with at least 2 days between conditions. Responses were
examined following a control condition with 4th i.c.v. vehicle (1 µl aCSF) and two doses
of MTII: 0.1 nmol and 1.0 nmol (dose selection based on (Haynes et al., 1999; Murphy et
al., 2000)). HR, TC, and SPA were continuously monitored for 8 h at 5-min intervals (Tc
and SPA) or 30-sec intervals (HR) in rats with implanted HRC-4000 transponders. TIBAT
was monitored every hour for 7 h in Experiment 1.

Experiment 2: Effects of systemic MC-R ligand injection on energy expenditure. This
experiment was designed to determine whether any of the energy balance effects seen
with 4th i.c.v. MTII injection could be attributed to actions on peripheral MC-Rs via drug
efflux from the brain. All other features of the design were identical to Experiment 1
except that vehicle (0.2 ml saline) and MTII (1.0 nmol in 0.2 ml saline) were injected i.p.
(n=12).
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Experiment 3: Effects of stimulating medullary raphe MC4-Rs via intraparenchymal
MTII injection on energy expenditure. All rats received two counterbalanced conditions
(100 nL injections of aCSF or MTII 10 pmol) separated by at least 2 days. Pilot studies
determined that 5 or 10 pmol of MTII delivered 4th i.c.v. were without effect on Tc – data
not shown. A: In one set of rats (n=8), TIBAT and SPA were monitored with G2
transponders every 5 minutes for 8 h. B: In a second set of rats (n=12), HR, Tc, and SPA
were monitored with HRC 4000 transponders for 8 h at 5-min intervals (Tc, SPA) and
30s intervals (HR).

Experiment 4: Effects of stimulating caudal brainstem MC-Rs via 4th i.c.v. injection on
IBAT temperature in chronic decerebrate rats and intact control rats. Diet
maintenance: Chronic decerebrate rats (CD) do not spontaneously ingest food (Grill
and Norgren, 1978); therefore they were maintained with four daily gastric intubations
of 9 ml of a liquid diet (AIN 76A rodent diet, Research Diets, New Brunswick, NJ). This
maintenance regime provides 79 kcal/d and adequate hydration; rats gain weight on
this regime. Feedings were separated by intervals of at least 2 h. CD and gavage-fed
(GF) intact control rats were maintained on this feeding paradigm except as noted below
during experimental testing. TC of CD rats is more variable than that of GF control rats.
Rectal temperature was measured at each gavage feeding and rats were cooled or heated
if TC was below 34.0 or above 38.5oC (except during experimental testing). Test days:
Experimental design was identical to that of Experiment 1, with the exception of the
dose. All rats (CDs: n=10, GF: n=9) were tested under control condition: 4th i.c.v.
vehicle (1 µl aCSF) and 1.0 nmol MTII.

Experiment 5: Effects of stimulating caudal brainstem MC-Rs via 4th i.c.v. MTII
injection on core temperature, heart rate and activity in chronic decerebrate and in
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intact rats with and without oral food access. Diet maintenance: CD (n=6) and GF
control (n=11) rats were maintained as in Experiment 4. A third group, meal-fed intact
rats (n=11), was included. These rats had oral access to the same diet that was intubated
in the other two groups. Meal-fed rats were presented with 9 mL of liquid diet at the
same times that the other groups received the diet by gavage. In all cases the 9 mL
aliquot was consumed within 5-10 minutes. The feeding maintenance condition of the
intact rats in the GF and meal-fed oral access groups were subsequently reversed in
order to allow within-subject comparison. Rats were re-tested with MTII and vehicle
injections after two weeks on a given feeding maintenance regime. Test days:
Experimental design was identical to that of Experiment 1.

Experiment 6: Effects of stimulating medullary raphe MC-Rs via intraparenchymal
MTII injection on energy expenditure in chronic decerebrate and gavage fed intact
rats. CD (n=4) and GF intact controls (n=5) rats received medullary raphe injections
early in the light cycle. The design was identical to that of Experiment 3. TIBAT
temperature was recorded every hour for 7 h.

Statistical analysis. All energy expenditure parameters were analyzed by ANOVAs on 5
or 6 h post-injection averages and followed by post-hoc t-tests and Tukey’s honestly
significant difference test as appropriate. Twenty-four h food intake and body weight
were analyzed by ANOVA followed by post-hoc t-tests and Tukey’s honestly significant
difference test as appropriate. All statistical analysis was conducted using Statistica
software (Tulsa. Oklahoma). Differences were considered significant at P<0.05.
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RESULTS

Experiment 1: Core temperature: Figure 2.1A shows that 4th i.c.v. injection of each dose
of MTII increased TC for the 6 h post injection period in neurologically intact rats. A
one-way ANOVA examining treatment effects on average post-injection TC values
revealed a significant drug treatment effect [F(2, 20) = 8.12, P < 0.005]. Post hoc
analysis revealed a significant effect of both MTII doses on TC (0.1 nmol; P < 0.05, 1.0
nmol: P < 0.005). IBAT temperature: Figure 2.1D shows that MTII significantly
increased TIBAT [F (2, 16) = 8.39, P < 0.005]. Both MTII doses significantly elevated TIBAT
(0.1 nmol; P < 0.005, 1.0 nmol: P < 0.05). A short latency increase in all measurements
apparent in the vehicle condition reflects the animals’ arousal associated with the
injection procedure. For the 1.0 nmol MTII dose however, some rats did not show the
transient elevation in TC or TIBAT giving rise to the impression that temperature
parameters declined to this dose. This initial response was however variable and not
statistically significant. Heart rate: Figure 2.1B shows that MTII dose-dependently
increased HR, compared with saline control. A one-way ANOVA of average HR values
for the 6 h period post-injection yielded a significant drug effect [F(2, 20) = 33.33, P <
0.0001]; post hoc analysis showed a significant effect of both doses of MTII on HR (0.1
nmol; P < 0.0005, 1.0 nmol: P < 0.0001). Spontaneous locomotor activity was not
significantly increased by 4th i.c.v. MTII [F (2, 20) = 2.45, P = 0.11] (Figure 2.1C). Food
intake and body weight: Both MTII doses significantly decreased 24 h food intake [F (2,
20) = 17.28, P < 0.0001] and body weight [F (2, 20) = 17.75, P < 0.0001] (Figure 2.1EF).

Experiment 2. Peripheral delivery (i.p.) of the higher dose of MTII (1.0 nmol) was
without effect on all of the measured energetic and food intake parameters (Figure 2.2).
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Experiment 3: A, TIBAT group: Figure 2.3E is a reconstruction of the injection sites for
the 8 animals tested. Microscopic analyses of the dye injection revealed that 7 rats had
placements within the medullary raphe. Figure 2.3A shows that average TIBAT was
significantly increased (P < 0.005) after 10 pmol MTII injection. Average SPA was also
increased (P < 0.05) (Figure 2.3B). No significant changes were observed in 24 h food
intake or 24 h body weight of these rats (Figure 2.3C-D). B, Core temperature and heart
rate group: Figure 2.4F reconstructs the injection sites of a second group of animals
and reveals that 9 rats had medullary raphe placements. Figure 2.4A-E displays the
physiological response of the 9 rats with confirmed medullary raphe placements and
shows that MTII injection significantly increased TC and HR (P < 0.05 and P< 0.0001).
These rats also showed a decrease in 24 h food intake following MTII, while SPA and 24
h body weight did not change significantly. Comparison of the injection sites in Figures
2.3E and 2.4F revealed that on average, the medullary raphe placements of the first
group were caudal to those of the second group. These placement differences may
account for the between group differences in SPA and food intake responses.

Experiment 4: Figure 2.5A shows that MTII (1.0 nmol) produced a large and long
duration elevation in TIBAT in CD rats. Two-way ANOVA (neurological preparation and
drug treatment as main variables) revealed a significant interaction of drug and
neurological preparation [F (1,17) = 33.85, P < 0.0001]. Post hoc test showed that there
was a significant effect of MTII on CD TIBAT (P≤ 0.0001), but surprisingly no effect on
GF control rats (P = 0.212) (see Figure 2.7D). The absence of an energy expenditure
effect in GF intact rats contrasted with the potent energetic effects of MTII observed in
the chow-fed intact rats of Experiment 1 and suggested that oral access to food in intact
animals could be a relevant variable in the MTII driven sympathetic responses. This
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finding encouraged inclusions of a second dose of MTII (0.1 nmol) and the addition of
an oral food access meal-fed control group that was in Experiment 5.

Experiment 5: For chronic decerebrate rats, 4th i.c.v. administration of MTII
significantly increased TC, HR and SPA [TC: F (2,10) = 4.97; P < 0.05, HR: F (2, 10) =
19.99; P < 0.0005, SPA: F (2, 10) = 5.81; P < 0.05] (Figure 2.5B-D). In meal-fed control
rats with oral access to liquid diet, MTII treatment also significantly increased TC and
HR [TC: F (2,20) = 5.10; P < 0.05, F (2, 20) = 22.26; P< 0.0001] (Figure 2.7A-B).
Consistent with the TIBAT results for GF intact rats in Experiment 4, there was no overall
significant effect of MTII on TC or SPA in GF controls (Figure 2.7A, C). While TIBAT was
increased under baseline conditions in GF rats as compared to intact chow fed controls,
which could potentially contribute to lack of effect of MTII, the TC of GF and chow fed
rats after vehicle treatment was not significantly different, yet MTII effect was still not
present in GF rats pointing to other mechanisms behind the lack of effect then increased
baseline temperature. Although significant tachycardia was noted in these MTII treated
GF rats [GF: F (2, 20) = 11.16; P < 0.0005] it was attenuated compared to the CDs or the
meal-fed oral access controls (Figure 2.7B). Twenty-four h body weight was significantly
decreased in the meal-fed rats with oral food access [F (2, 20) = 5.3; P < 0.05] following
MTII delivery. Interestingly, body weight was also reduced by MTII in GF controls, [F
(2, 20) = 6.3; P < 0.05] (Figure 2.8). Post hoc tests revealed that this effect is produced
by the highest dose of MTII in both groups. CD body weight declined after both MTII
doses; however that effect was not statistically significant. All groups had identical
energy intake, indicating that the MTII effect on energy expenditure provided the basis
for the observed suppression in body weight. It should be noted that the values for Tc,

26

TIBAT and HR measured at baseline were the same for decerebrate and intact control
rats.

Experiment 6: Reconstruction of the parenchymal placements revealed that the
injection sites in 3 rats were located within the medullary raphe (Figure 2.6B). The
average TIBAT in CD rats with the confirmed medullary raphe placements was
significantly increased (P < 0.05) after 10 pmol MTII injection (Figure 2.6A). No MTIIdriven TIBAT effect was observed in GF controls (Figure 2.7E).

DISCUSSION

We show that MC-R-bearing caudal brainstem neurons and their local caudal
brainstem projections to sympathetic effectors play a critical and previously
unrecognized role in the central melanocortin system’s contribution to energy
expenditure control. Long lasting and robust increases in thermogenesis and
cardiovascular activity were observed after hindbrain ventricular delivery of MTII to
neurologically intact control and to CD rats. Further support for the caudal brainstem
MC-R site of action comes from the parenchymal injection results where IBAT
thermogenesis and tachycardia were triggered by picomolar MTII stimulation of the
medullary raphe MC4-Rs. These data are the first to demonstrate a functional effect of a
ventricle sub-threshold MC-R agonist dose delivered to the MC4-R bearing neurons of
the medullary raphe (Mountjoy et al., 1994; Kishi et al., 2003). The hyperthermia, IBAT
thermogenesis and tachycardia observed in CD rats following 4th i.c.v. and parenchymal
MTII injections supports the hypothesis that hindbrain MC-R stimulation engages
endemic circuits that link autonomic outflows to thermogenic and cardiac effectors in
the absence of forebrain processing or forebrain-caudal brainstem communication.
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The qualitative profile of results for CD and for chow-fed control rats was similar;
increases in energetic and cardiovascular parameters were observed in both groups after
hindbrain MC-R stimulation. Quantitatively, however, the magnitudes of the mean
energetic responses were two- (HR) to four-fold (temperature) greater in CD rats than
in intact rats after 4th i.c.v. MTII application (Table 1). Quantitative differences between
neurological groups were also observed with application of 10 pmol of MTII to the
medullary raphe. Here, intact chow-fed rats increased IBAT temperature by ~0.5oC on
average. By contrast, the same dose of MTII increased IBAT temperature of a CD rat by
~3.0oC (Figure 2.3A and 2.6A). There are several interpretations for these quantitative
differences between decerebrate and intact rats. Endogenous agonist for the caudal
brainstem MC-Rs originates from two anatomically disparate sources; one in the
hypothalamic arcuate (ARC) nucleus (Knigge et al., 1981) and the other in the hindbrain
NTS commissural nucleus (Joseph et al., 1983). Transection of the descending
projections from ARC POMC neurons, could eliminate a significant percentage of the
endogenous agonist for a given caudal brainstem nucleus. This could result in a
compensatory increase in expression of MC-Rs in hindbrain nuclei. Upregulation of
MC-Rs in response to decreased agonist availability has been reported (Harrold et al.,
1999). While projections from both ARC POMC and NTS POMC neurons terminate in
the caudal brainstem, it is not clear what the source[s] of endogenous agonist is for each
of the individual MC-R expressing hindbrain nuclei. For each nucleus it is possible that
the agonist is supplied entirely by NTS POMC neurons, ARC POMC neurons or some
combination of the two (Jacobowitz and O'Donohue, 1978). Sim et al (Sim, 1994)
showed that ARC POMC projections innervate midline caudal brainstem nuclei whereas
lateral caudal brainstem regions receive projections from NTS POMC neurons; in some
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cases, structures received terminal fields from both sources. In collaboration with H.R.
Berthoud we have begun to examine tissues from decerebrated rats to quantify the
percentage of alpha-melanocyte stimulating hormone (MSH) fibers that originate in
ARC POMC neurons and project to various hindbrain MC-R bearing nuclei. For the NTS,
we recently showed that ~70% of the MSH fibers terminating in all subregions of the
NTS, originate in ARC POMC neurons (Berthoud HR, 2008). Additional work is needed
to determine the source of MSH ligand for RPa, RVLM and other relevant hindbrain
nuclei and whether eliminating a major source of endogenous ligand (ARC POMC
neurons) increases exogenous agonist binding and receptor expression in caudal
brainstem nuclei.

The activation of MC-Rs is also influenced by the endogenous antagonist –
agouti-related protein (AgRP) – that arises in ARC neurons (Ollmann et al., 1997). It is
generally thought that antagonist-containing neurons project most heavily to forebrain
areas (Bagnol et al., 1999; Haskell-Luevano et al., 1999). However, hindbrain
projections have also been reported (Broberger et al., 1998). The transection of
descending AgRP projections may provide another explanation for the greater response
to MTII observed in CD. The elimination of AgRP projections to hindbrain neurons that
also receive MSH fibers (regardless of their origin) may result in greater MC-R
activation and potentially contribute to the observed effects. A different type of
interpretation for the greater response magnitude in CD rats relates to the role of
forebrain-hypothalamic nuclei in mediating fine-grained response control. For example,
heart rate is increased in response to skin cooling, and contributes to the dispersion of
the heat produced by sympathetic activation of brown adipose tissue. For intact rats,
there is a significant correlation between heart rate and ambient temperature over the 4o
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to 23o C range. By contrast, for decerebrate rats, the heart rate response to an
intermediate cold temperature is as robust as that observed with the coldest
temperature, indicating a loss of fine-grained control in the absence of connections with
the forebrain (Grill et al., 2005). A similar explanation for the greater MTII-stimulated
responses of the CD rats could apply in the current data.

The responses of gavage-fed intact rats differed qualitatively from those of chowfed intact rats and oral-fed rats (Table 1). The variability of these responses was great,
however, yielding trends but no significant differences between the intact rat subgroups.
Nonetheless, the pattern of these between-group differences is clear, with lesser
response magnitude for the gavage-fed intact group than for the two intact groups with
oral access to food. This outcome suggests a role for oral stimulation in the observed
responses. Saito et al (Saito et al., 1989) demonstrated that oropharyngeal stimulation
contributes to IBAT thermogenesis. Gavage feeding reduced oropharyngeal stimulation
and decreased IBAT norepinephrine turnover relative to that seen in oral-fed rats. Our
studies are consistent with the view that gavage feeding decreases the magnitude of
sympathetically mediated energy expenditure output. Our data place components of the
melanocortin system within the SNS output circuitry that is altered by oral exposure to
food. Two provisos are worth noting. First, CD rats responded robustly to MC-R agonist,
yet they were gavage fed. This suggests that the inhibitory effect of bypassing the mouth
on MTII-driven energetic responses is forebrain mediated. Second, even though the
energetic response magnitude of gavage-fed intact rats was attenuated, the animals still
exhibited significant weight loss after the drug treatment (Figure 2.8). This result
underscores the contribution of MC-R induced energy expenditure to body weight
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control, as the food intake of these rats was matched to that in the vehicle condition
such that weight loss could not be attributed to the anorectic effect of the treatment.

The energetic effects obtained from selective stimulation of the MC4-R-bearing
neurons of the medullary raphe and with 4th ventricular agonist delivery, highlight the
role of hindbrain MC-R-bearing neurons in the control of sympathetic, thermic and
cardiac responses. That said, there is also a role for hypothalamic-forebrain processing
in melanocortin mediated energetic effects. Many reciprocal neural projections exist
between hypothalamic nuclei (especially PVN, ARC and the lateral hypothalamic area)
and hindbrain nuclei. In fact, the literature on sympathetic outflows and energy
expenditure control emphasizes a role for these hypothalamic nuclei [for review see
(Richard, 2007)]. The neural circuitry underlying the expression of thermic and cardiac
responses to hindbrain MC-R stimulation may well involve descending hypothalamic
projections. We have already discussed that ARC POMC neurons project to a variety of
sympathetic pre-motor targets in the hindbrain and therefore it is appropriate to
consider that the application of MC-R agonist to MC4-R hindbrain neurons mimics, at
least in part, the effects of endogenous ligand input from ARC. In addition, nonmelanocortinergic projections from hypothalamic nuclei may also play a role in the
control of MC-R-driven energetic response. MC-R-bearing PVN neurons receive ligand
from ARC and project to the caudal brainstem ((Horvath and Diano, 2004)). At the
same time, the results from the decerebrated rats make clear that forebrain processing
and forebrain-brainstem communication are not required for caudal brainstem
stimulated responses and that downstream circuits endemic to the caudal brainstem
mediate the observed responses. The current data are consistent with those from
previous studies from our lab (Williams et al., 2003) that show that the increase in UCP-
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1 gene expression driven by 4th ventricular MTII can be mediated by circuitry intrinsic to
the caudal brainstem and spinal cord.

The increased energetic response to 4th ventricular application of MTII in chow-fed
intact rats reported here is consistent with results from an earlier report by Zheng et al
(Zheng et al., 2005). However, responses in that study were of lesser magnitude and
duration than those observed here with MTII doses within a similar range. In the Zheng
et al study, rats had access to food during energetic response recordings and recordings
took place during the dark/active phase. In our study, rats were tested in the light phase
in the absence of food. These paradigmatic differences appear to explain the observed
differences in responses. We observed that rats stimulated with MTII in the light phase
without access to food have greater response magnitude and duration than when the
same rats are examined in the dark phase with access to food (unpublished
observations).

We showed that hindbrain MC-Rs contribute to the energy expenditure observed
with central melanocortinergic stimulation. This result would seem consistent with the
recent perspective of Balthasar et al (Balthasar et al., 2005). These investigators
selectively expressed MC4-Rs in neurons of the PVN and amygdala in mice otherwise
lacking the receptor. They found that this selective MC4-R expression reversed the
hyperphagia seen in the MC4-R knockout mouse but did not increase the reduced
energy expenditure profile of the knockout. Balthasar et al (Balthasar et al., 2005)
suggest that the energy intake and energy expenditure effects of the central
melanocortin system are controlled by anatomically distinct portions of the system.
While we would agree that the melanocortin contribution to energy balance control is
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distributed across different brain regions, our data and those of others [e.g. see (Grill
and Kaplan, 2002; Taylor et al., 2007)] do not support the view that feeding function is
uniquely associated with basal forebrain elements of the melanocortin system and that
energetic function is controlled uniquely by more caudal elements of the system. In our
view, stimulation of MC-Rs in a variety of central sites, including the hypothalamus and
caudal brainstem, reduces feeding and increases energetic response. For example, the
present findings show that in addition to the energetic effects of 4th ventricular MC-R
agonist delivery, food intake was also significantly reduced. Previous work shows that
hindbrain parenchymal application of pmol doses of MTII or the synthetic MC3/4R
antagonist SHU-9119 results in a respective decrease or increase in food intake
(Williams et al., 2000a). The idea that stimulation of anatomically disparate receptors
can drive the same functional effect is however, not new. We and others have already
shown that the feeding effect of central injection of leptin, urocortin, ghrelin,
neuropeptideY, fenfluramine and norepinephrine is observed with basal forebrain, as
well caudal brainstem ligand application (Grill and Kaplan, 2002; Faulconbridge et al.,
2005; Taylor et al., 2007). It seems then that such a similarity in the functional output
resulting from stimulation of anatomically distinct sites represents a degree of
redundancy in the melanocortin system. While this suggests common outputs, it is
likely that there are differences in the pattern of input received by MC-R bearing nuclei
in different regions of the brain. Both energy intake and expenditure change in response
to long term exposure to calorie dense diets (Bachman et al., 2002; Landsberg, 2006)
and also in response to pathogens. The melanocortin system plays a role in mediating
the energetic effects triggered by these diverse physiological conditions (Butler et al.,
2001; Voss-Andreae et al., 2007). It is possible that responses resulting from these
distinct challenges are processed at different levels of the brain, making the receptors
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divergent based on input, but still producing the same functional output – decrease in
intake and increase in expenditure.

MC-Rs are expressed on peripheral organs, like the heart (Mountjoy et al., 2003)
and adrenal medulla (Mountjoy and Wild, 1998), implicated in metabolic and
cardiovascular activity. Peripheral application of high doses of MC-4R agonist increases
heart rate, blood pressure, IBAT temperature, as well as locomotor activity (Nordheim
et al., 2006). Therefore, some part of the energetic effects obtained after central
application of MC-R agonists to the brain may arise from an action on peripheral
receptors. To evaluate this possibility we applied the highest dose of the agonist used
centrally to the periphery and showed no effect on any measured energy expenditure
parameter. While this result does not eliminate the potential role of the peripheral MCRs in energy expenditure, it confirms that energetic effects observed in our study are
induced by stimulation of central and not peripheral receptors.

We showed that hindbrain targeted MC-R stimulation and medullary raphe MC4-R
agonist injection increases energetic responses including hyperthermia, IBAT
thermogenesis and tachycardia. The source of endogenous agonist for caudal brainstem
MC-Rs arises from both local (NTS) and forebrain (ARC) sources. It is still unclear to
what extent each nucleus contributes to the endogenous agonist supply of the specific
MC-R bearing nuclei of the caudal brainstem mediated energetic responses under
normal conditions. Therefore, the neural circuitry underlying the expression of thermic
and cardiac responses to hindbrain MC-R stimulation may well involve descending
hypothalamic projections. That the same pattern of response was observed in
decerebrate and intact rats shows however, that the output circuitry responsible for the
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observed effects lies within the hindbrain and does not require forebrain processing or
forebrain-caudal brainstem communication. The results of this study suggest future
investigations designed to determine the range of factors and environmental conditions
(e.g. diet, pathogens, cold exposure) that engage the previously underappreciated caudal
brainstem portion of melanocortin system as it participates in the control of energy
expenditure.
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Figure 2.1: Effect of caudal brainstem melanocortin receptor stimulation with 4th
ventricular MTII on (A) core temperature, (B) heart rate, (C) spontaneous activity and
interscapular brown adipose tissue temperature (TIBAT) (D) in chow fed neurologically intact rats.
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Line graphs represent across-rat average parameter measurements through the recording period.
The bracketed time period on the line graph x-axis indicates the periods used in the histograms.
The histograms next to line graphs provide 6 h or 5 h (TIBAT) post-injection averages + SEM for
each parameter at each dose. Effect of 4th ventricular MTII injection on 24 h food intake (E) and
24 h change in body weigh (F) in chow fed intact rats. Food was made available to animals 8 h
after injections and through the 12 h period of dark cycle. Histograms represent means + SEM.
*P < 0.05, **P < 0.005, ***P < 0.0005.
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Figure 2.2: Effect of peripheral (i.p.) MTII treatment on (A) core temperature, (B) heart
rate, (C) spontaneous activity, (D) 24 h food intake and (E) 24 h change in body weigh in chow
fed intact rats. Line graphs represent across-rat average parameter measurements through the 8
h recording period. The bracketed time period on the line graph x-axis indicates the periods used
in the histograms. Histograms represent means + SEM.
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Figure 2.3: Effect of stimulation of medullary raphe MC4-Rs via parenchymal
injection of 10 pmol MTII on (A) interscapular brown adipose tissue temperature (TIBAT), (B)
spontaneous activity, (C) 24 h food intake and (D) change in body weight. Line graphs represent
across-rat average parameter measurements through the 8 h recording period. The bracketed
time period on the line graph x-axis indicates the periods used in the histograms. Histograms
represent means + SEM. *P < 0.05, **P < 0.005. (E) Reconstruction of injection sites based on
microscopic analysis of dye injection at the same volume (100 nL) as the melanocortin agonist.
Microscopic analysis revealed that 7 of 8 rats had placements within the medullary raphe (raphe
pallidus, raphe obscurus, raphe magnus). Solid line ovals indicate instances where the dye
injection placement was within the medullary raphe (positive placements). Dotted line circles
represent negative placements (injection sites that were judged to be outside of medullary raphe).
Placements shown were between -10.52 and -11.60 mm from bregma. (Paxinos, 1998)
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Figure 2.4: Effect of 10 pmol MTII stimulation of medullary raphe MC4-Rs on (A)
core temperature, (B) heart rate, (C) spontaneous activity, (D) 24 h food intake and (E) 24 h
change in body weigh. Line graphs represent across-rat average parameter measurements
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through the 8 h recording period. The bracketed time period on the line graph x-axis indicates
the periods used in the histograms. Histograms in a-c represent 6 h means + SEM. *P < 0.05, **P
< 0.005, ***P < 0.0005. (F) Reconstruction of injection sites based on microscopic analysis of
dye injection at the same volume (100 nL) as the melanocortin agonist. Microscopic analysis
revealed that 9 of 12 rats had placements within the medullary raphe. Solid line ovals mark the
area of the dye injection for each rat with confirmed medullary raphe placement. Dotted line
circles represent injection sites that were judged to be outside of medullary raphe. Placements
shown were between -10.30 and -11.30 mm from Bregma. (Paxinos, 1998)
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Figure 2.5: Effect of 4th ventricle MTII injection in chronic decerebrate rats on (A)
interscapular brown adipose tissue temperature (TIBAT), (B) core temperature, (C) heart rate and
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(D) spontaneous activity in chronic decerebrate rats. Line graphs represent across-rat average
parameter measurements through the recording period. The bracketed time period on the line
graph x-axis indicates the periods used in the histograms. Histograms represent 6 h or 5 h (TIBAT)
means + SEM. *P < 0.05, **P < 0.005.
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Figure 2.6: Effect of medullary raphe MC4-R stimulation with 10 pmol MTII in
chronic decerebrate rats on (A) interscapular brown adipose tissue temperature (TIBAT). Line
graph represents across-rat average parameter measurements through the 8 h recording period.
The bracketed time period on the line graph x-axis indicates the periods used in the histograms.
Histogram represents 6 h means + SEM. *P < 0.05. (B) Reconstruction of injection sites based
on microscopic analysis of dye injection at the same volume (100 nL) as the melanocortin agonist.
Microscopic analysis revealed that 3 of 4 rats had placements within the medullary raphe. The
dye injection placement for each animal is represented by solid line ovals. Dotted line circles
represent negative placements. Placements shown were between -10.52 and -11.30 mm from
Bregma. (Paxinos, 1998)
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Figure 2.7: Effect of caudal brainstem MC-R stimulation with 4th i.c.v. delivered
MTII in gavage-fed and meal-fed neurologically intact control rats on (A) core
temperature, (B) heart rate (C) spontaneous activity and (D) interscapular brown adipose tissue
temperature (TIBAT). Effect of medullary raphe MTII delivery to gavage-fed rats on TIBAT (E).
Histograms represent means + SEM. *P < 0.05, **P < 0.005, ***P < 0.0005.
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Figure 2.8: Effect of 4th i.c.v. MTII treatment on 24 h body weight change of gavagefed and meal-fed neurologically intact rats. Note: all animals had identical food intake
(either delivered by gavage or consumed in entirety during a meal), therefore all noted changes in
body weight are a result of treatment induced changes in energy expenditure. Histograms
represent means + SEM. *P < 0.05.
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CHAPTER 3
HYPOTHALAMIC AND HINDBRAIN MELANOCORTIN RECEPTORS
CONTRIBUTE TO THE FEEDING, THERMOGENIC AND
CARDIOVASCULAR ACTION OF MELANOCORTINS2

ABSTRACT
Forebrain Forebrain ventricular delivery of melanocortin receptor (MC3/4R) agonist
(MTII) increases energy expenditure (EE) and decreases food intake (FI). As forebrain
ventricular delivery provides ligand to various anatomically distributed MC3/4Rbearing nuclei it is unclear which of the receptor subpopulations contributes to the
feeding suppression and to the sympathetic-thermogenic effects observed. The literature
indicates that re-expression of MC4R in the paraventricular nucleus (PVN) affects the
feeding but not the energetic phenotype of the MC4R knockout; suggesting that
divergent MC4R populations mediate EE (hindbrain) and FI (hypothalamus) effects of
stimulation. Not consistent with this view are data indicating that PVN sympathetic premotor neurons express MC4Rs and that feeding effects are induced from hindbrain
MC4R sites. Therefore we hypothesize an opposing perspective: that stimulation of
anatomically diverse MC3/4R-bearing nuclei triggers energetic as well as feeding effects.
To test this hypothesis, ventricle subthreshold doses of MTII (5 and 10pmol) were
applied in separate experiments to six hindbrain and hypothalamic sites; core
temperature (Tc), heart rate (HR), spontaneous activity (SPA) and FI were measured in

2

These results were reported at the 2008 meeting of Society for Ingestive Behavior, in Paris, France. This
work was supported by NIH grants DK-21397 and NRSA NS-059254.
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behaving rats. Nucleus tractus solitarius and PVN stimulation increased Tc, HR, and
SPA and decreased FI. Rostral ventrolateral medulla, parabrachial nucleus and
retrochiasmatic area stimulation increased Tc, HR, but not SPA, and decreased FI. The
response profile differed to some extent for each nucleus tested, suggesting differential
output circuitries for the measured parameters. Data are consistent with the view that
energetic and feeding responses are not controlled by regionally divergent MC3/4Rs and
can be elicited from multiple, anatomically distributed MC3/4R populations.

INTRODUCTION

Humans with melanocortin receptor-4 receptor (MC4R) mutation are
hyperphagic and obese (Yeo et al., 1998; Ma et al., 2004). They also exhibit lower energy
expenditure (Cai et al., 2006) and decreased cardiovascular parameters (heart rate and
blood pressure)(Greenfield et al., 2009). MC4R knockout mice show a similar energy
balance profile.

These results, and others, support the view that the central

melanocortin system is an important element of the CNS circuits controlling food intake
and energy expenditure. Ventricular pharmacologic stimulation of central melanocortin
receptors (MCRs; MC3 and MC4Rs) increases energy expenditure and cardiovascular
parameters, and decreases food intake(Grill et al., 1998; Murphy et al., 2000; Skibicka
and Grill, 2008a). It is unclear however which of the anatomically distributed MCR
subpopulations contribute to the food intake and to the sympathetic-energetic effects
observed.

Despite the broad anatomic distribution of CNS MCRs, especially MC4R, MCRexpressing neurons in the hypothalamus are viewed as the principal site of action for the
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food intake as well as for the energy expenditure effects of melanocortin ligand
stimulation. This view, especially pertaining to food intake, is supported by data
indicating that 3rd ventricular injections of MC3/4 R agonist (MTII) as well as intraparenchymal injections into the paraventricular hypothalamic nucleus (PVN) reduces
food intake (Murphy et al., 2000; Wirth et al., 2001). Additional support for this
anatomical perspective comes from the results showing that re-expression of MC4Rs in
the PVN (and in some other amygdala and hypothalamic neurons) in obese MC4R
knockout mice reverses their hyperphagia to a level of food intake seen in wild-type
control mice(Balthasar et al., 2005).

The obesity of these selective MC4R-expressing mice is not, however, fully
reversed as their energy expenditure (measured by oxygen consumption) is not affected
by the treatment, in contrast to their feeding. This result is surprising since it is clear
that MC4R expressing parvocellular PVN neurons are sympathetic pre-motor neurons
whose output contributes to the control of brown adipose tissue (BAT) thermogenesis
(Cano et al., 2003b; Voss-Andreae et al., 2007; Song et al., 2008). This contrasting
pattern of energy balance effects led to a new hypothesis about the control of energy
balance function exerted by anatomically distinct MCRs – that hypothalamic/PVN
MC4R expressing neurons contribute to control of food intake and MC4R expressing
sites elsewhere, likely in the caudal brainstem, contribute to the energy expenditure
effects of melanocortins.

Consistent with this organizational perspective several caudal brainstem nuclei
contain sympathetic pre-motor neurons that express MC4R and contribute to the
control of BAT thermogenesis including the raphe pallidus, rostral ventrolateral medulla
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(RVLM), nucleus of the solitary tract (NTS) and the pontine parabrachial nucleus (PBN)
(Voss-Andreae et al., 2007). Hindbrain ventricular or raphe pallidus injection of the
MC3/4R agonist MTII increases energy expenditure (elevating core and BAT
temperature) and heart rate (Skibicka and Grill, 2008a) (this combination appears to
facilitate heat distribution and increases in uncoupling protein-1 expression in BAT
tissue (Williams et al., 2003). While these caudal brainstem MCR-driven energetic
effects are consistent with the idea of hypothalamic-caudal brainstem divergence of
function for feeding versus energy expenditure other published findings are not.
Application of picomolar doses of MC3/4R agonist (MTII) and antagonist (SHU-9119)
to the NTS results respectively in robust food intake inhibition or hyperphagia (Williams
et al., 2000a; Zheng et al., 2005; Li et al., 2007)); low-dose agonist stimulation of raphe
pallidus inhibits feeding (Skibicka and Grill, 2008a). These findings are inconsistent
with the notion of that the feeding effects of CNS MCR stimulation are localized to
hypothalamic MCR stimulation. Rather, these results appear to indicate that the energy
balance effects of melanocortins are anatomically distributed and not regionally
segregated.

To better distinguish between the applicability of these two competing views of
the relationship between MCR location and the control of energy intake and
sympathetic-energy expenditure responses, investigation of responses obtained by
stimulating a variety of individual MC4R expressing nuclei at the level of the
hypothalamus and the caudal brainstem are required. Here we pursue such studies.
Using ventricle subthreshold, picomolar doses of the MC3/4R agonist MTII experiments
assessed the energy balance response profiles observed with direct parenchymal
stimulation of six different MC4R bearing nuclei, two within hypothalamus [PVN,
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Retrochiasmatic area (RCh) and anterior hypothalamic area] and three within the
caudal brainstem (NTS, RVLM and PBN). For each nucleus examined MCR expression
and connections to sympathetic outflow have been affirmed. The three caudal brainstem
sites are anatomically segregated such that stimulation of one would not indirectly
stimulate the other. Given that two hypothalamic sites are relatively close to each other
a third site, the anterior hypothalamic area (AHA), was included as an anatomical
control for the spread of injected ligand.

Stimulation of all but one of the sites tested led to an increase in core
temperature and heart rate, a decrease in food intake and body weight, and in some
cases increases in activity. These results are consistent with the hypothesis that energy
balance effects of melanocortins are distributed across many anatomically distinct sites
within the CNS.

METHODS:

Subjects
Male Sprague Dawley rats (Charles River Laboratories, Wilmington, MA), weighing
300–400 g at surgery and housed individually in plastic bins maintained on a 12-h light,
12-h dark cycle (0800 h lights on), participated in the four experiments described below.
Pelleted food (Purina 5001; St. Louis, MO) and water were available ad libitum unless
otherwise noted. All procedures conformed to the institutional standards of animal care
and use (University of Pennsylvania).
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Surgery
Rats were anesthetized with ketamine (90 mg/kg), xylazine (2.7 mg/kg), and
acepromazine (0.64 mg/kg) delivered im.

Cannula implantation.
All rats in received a guide cannula (22 gauge; Plastics One, Inc., Roanoke, VA) with its
tip stereotaxically positioned 1.0 (AHA) or 2.0 mm above the target parenchymal site.
Following coordinates were used: 1) NTS: 0.7mm from the midline, on the occipital
suture, and 6.9mm ventral to the skull, with injector aimed 8.9mm ventral from skull.
2) RVLM: 2mm from the midline, 1.8mm rostral to occipital suture, and -7.9mm ventral
to the skull, with injector aimed 10.9mm ventral to skull. 3) PBN: 2.0mm lateral to
midline, 9.5-mm posterior to bregma, and 4.5-mm ventral to the dura, with injector
aimed 6.5-mm ventral to dura. 4) PVN: 0.5mm lateral to midline, 1.8-mm posterior to
bregma, and 5.7-mm ventral to the dura, with injector aimed 7.7-mm ventral to dura 5)
AHA: 0.5mm lateral to midline, 1.8-mm posterior to bregma, and 7.7-mm ventral to the
dura, with injector aimed 8.7-mm ventral to dura 6) RCh: 0.5mm lateral to midline, 1.8mm posterior to bregma, and 7.7-mm ventral to the dura, with injector aimed 9.7-mm
ventral to dura. Cannulas were attached to the skull with dental acrylic and jeweler’s
screws, and closed with an obturator. Cannula placement was verified histologically after
the experiment by examining the anatomical placement of an injection of pontamine sky
blue (100 nl volume matched drug delivery in the experiments) made at sacrifice. Only
rats whose dye injection site was found within the intended parenchymal site were
included in the physiological data analysis. For the NTS group an additional functional
verification was applied. The placement was assessed 7 days after the surgery by
measurement of the sympathoadrenal-mediated glycemic response to an injection of 5-
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thio-D-glucose [21 µg in 100nl artificial cerebral spinal fluid (aCSF)] (Ritter et al., 1981).
A post-injection elevation in baseline plasma glucose level of at least 100% was required
for subject inclusion using this verification criterion.

Telemetric transponder surgery.
Under anesthesia telemetric transponders (HRC 4000 VitalView; Mini
Mitter/Respironics, Bend, OR) for recording core temperature (TC), heart rate (HR), and
spontaneous physical activity (SPA) were inserted into the abdominal cavity, with the
leads positioned subcutaneously and secured to the chest muscles on either side of the
heart with sutures as described in (Skibicka and Grill, 2008a).

Experimental procedures.

Habituation training.
Before the start of experimental testing, rats were habituated to the handling and
injection procedures to be used during formal testing.

Testing days.
All rats received vehicle injections (100 nl aCSF) counterbalanced with one (RCh, AHA;
10pmol MTII) or two doses (NTS, RVLM, PBN, PVN; 5 and 10 pmol MTII) of MTII.
Core temperature, heart rate and spontaneous activity were recorded telemetrically for
1h before injections and for the 8h following injections; the frequency of measurement
was every 5 min (TC, SPA) or 1 min (HR). Food was removed just prior to injection time
(early in the light cycle, between 0930 and 1000 h) and returned 8 h later, late in the
light phase. Thereby, food was not available during the period of energeticcardiovascular response measurement. Food intake and body weight measurements
were performed 24 h after the injection of drug. Given this design, all noted differences
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in food intake reflect longer latency effects of MTII (from 8–24 h after injection). For ad
libitum-feeding rats, food was always available during the dark cycle. A minimum of a
48 h period intervened between experimental testing.

Statistical analysis:
Core temperature, HR and SPA were analyzed by ANOVA on post-injection 6 h average
values of each parameter and followed by student’s t-test or Tukey test as appropriate.
Twenty four hour food intake and body weight were analyzed by ANOVA and followed
by t-test or Tukey test as appropriate.

RESULTS

NTS: Microscopic assessment of the brains of rats in this group indicated that center of
the dye injection was located within the NTS at the level of 4th ventricle; dye also
reached the DMX in some cases. Figure 3.1 shows that MTII injection significantly
increased Tc (5 pmol: P < 0.05; 10 pmol: P < 0.0005), HR (5 pmol: P < 0.0005; 10 pmol:
P < 0.0005) as well as spontaneous activity (10 pmol: P < 0.05). Overnight food intake
and body weight were reduced by 10 pmol MTII treatment (P < 0.0005, P < 0.0005
respectively). The 5 pmol MTII dose did not yield significant changes in activity, food
intake or body weight.

RVLM: Microscopic analysis indicated that center of dye injection for these rats were
located within the RVLM, with small amounts of ink in some cases reaching near the
nucleus ambiguous. Figure 3.2 shows that MTII stimulation significantly increased Tc (5
pmol: P < 0.05; 10 pmol: P < 0.05), HR (5 pmol: P < 0.05; 10 pmol: P < 0.0005). No
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significant spontaneous activity changes were noted after MTII application to the RVLM.
Overnight food intake and body weight were reduced by 5 pmol MTII treatment (5 pmol:
P < 0.005), (5 pmol: P < 0.05), respectively.

PBN: The dye injection for this group was centered at the external lateral nucleus of
PBN with only trace amounts of ink reaching other PBN nuclei. Figure 3.3 shows that
MTII stimulation significantly increased Tc (5 pmol: P = 0.13; 10 pmol: P < 0.05), HR (5
pmol: P < 0.0005; 10 pmol: P < 0.0005) but not spontaneous activity. Overnight food
intake and body weight were reduced by the MTII treatment (5 pmol: P < 0.005; 10
pmol: P < 0.005), (5 pmol: P =0.055; 10 pmol: P < 0.05), respectively.

PVN: The dye injection for rats in this group was centered at the dorsal PVN. Figure 3.4
shows that MTII stimulation significantly increased Tc (5 pmol: P=0.23; 10 pmol: P <
0.05), HR (5 pmol: P < 0.0005; 10 pmol: P < 0.0005) and spontaneous activity (5 pmol:
P < 0.0005; 10 pmol: P < 0.0005). Overnight food intake and body weight were reduced
by the MTII treatment (5 pmol: P = 0.076; 10 pmol: P < 0.05), (5 pmol: P < 0.05; 10
pmol: P < 0.05), respectively.

RCh: Microscopic evaluation determined that in all rats in this group the dye injection
was centered in the RCh. Figure 3.5 shows that MTII stimulation significantly increased
Tc (10 pmol: P < 0.01) and HR (10 pmol: P < 0.0005) but had no effect on spontaneous
activity (10 pmol: P= 0.42). Overnight food intake and body weight were reduced by the
MTII treatment (10 pmol: P < 0.01), (10 pmol: P < 0.005), respectively.
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AHA: In order to show that the doses and volume chosen were selective for the target
nuclei tested this site was selected as an anatomical control placement for the relative
adjacency of PVN and RCh targets. MTII injected into the AHA did not produce any
significant changes in any of the measured parameters (Figure 3.6). The location of the
AHA directly adjacent to the two hypothalamic targets that yielded a positive effect (just
dorsally to RCh and just ventrally to PVN) and the lack of observed effects confirm that
this target served as a negative control area.

DISCUSSION
Each of the sites targeted in these studies - PBN, NTS, RVLM, PVN and RCh was selected for its expression of MC4Rs and its established connection to the
sympathetic outflow (Mountjoy et al., 1994; Mountjoy and Wild, 1998; Voss-Andreae et
al., 2007; Song et al., 2008). This phenotypic profile provided the foundation for the
hypothesis that direct melanocortinergic stimulation of these different hypothalamic
and hindbrain neurons could drive energetic and cardiovascular responses. The results
obtained are consistent with that hypothesis - direct administration of low, picomolar
doses of MC3/4R agonist into these areas triggered hyperthermia, tachycardia and in
some cases hyperactivity. Also noteworthy, stimulation of these sites induced anorexia
and body weight loss. The lack of an effect on any measured parameter from
melanocortinergic stimulation of the AHA site, intermediate between the PVN and RCh
sites, supports the interpretation that the observed effects arise from ligand application
to the targeted neurons. To our knowledge these are the first reports of the effects of
direct melanocortinergic stimulation in PBN and RCh, and the first assessment of the
energetic effects of PVN and RVLM MCR stimulation in a non-anesthetized rat.
Collectively, the data presented indicate that the energy intake and the energy
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expenditure effects of CNS MCR stimulation are mediated by an anatomically
distributed network of MCR-bearing neurons. These data are not consistent with an
anatomical organization of MCR-stimulated energy balance response where the control
of feeding and energetic-sympathetic responses is regionally segregated.

Hyperthermia
Stimulation of MCR expressing neurons in NTS, PBN, RCh and PVN increased
core temperature significantly (RVLM and hyperthermia is discussed later in the
paragraph). BAT thermogenesis driven by sympathetic outflows is a likely contributor
to the observed hyperthermia as both MC4R expression and neural connections to BAT
(retrograde viral tracing from BAT) are present in these nuclei (Voss-Andreae et al.,
2007). BAT temperature and UCP-1 gene expression was not measured in the current
study, however, 4th ventricular delivery of MTII gives rise to a profile of response that
includes hyperthermia, elevations in BAT temperature (Skibicka and Grill, 2008a) and
in BAT UCP-1 mRNA (Williams et al., 2003; Song et al., 2008). Direct MTII injection
into the caudal raphe (10 pmol, lowest effective dose) increases BAT temperature
(Skibicka and Grill, 2008a). Elevation in BAT temperature is also observed after PVN
MTII stimulation (50 pmol, lowest effective dose) in the hamster (Song et al., 2008).
This study is the first to show thermal effects of direct PBN melanocortin stimulation. A
contribution of PBN to the neural control of thermoregulation has been suggested by the
work of others. Electrical stimulation of PBN produces BAT hyperthermia and increases
oxygen consumption and bilateral PBN lesion disrupts the thermogenic response
triggered by environmental cooling (Kobayashi and Osaka, 2003). Lateral PBN neurons
are activated by skin cooling and may influence BAT thermogenesis via their rostral
projections to neurons of the hypothalamic medial preoptic area (Nakamura and
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Morrison, 2007). The contribution of PBN output to BAT thermogenesis could also
involve descending PBN projections (Hermann et al., 1997) to the raphe pallidus, a
region critical for the neural control of BAT thermogenesis (Morrison, 2003). While not
a focus of study for its effects on temperature, the connection between RCh neurons and
BAT (viral-tracing studies) and the MC4R expression in these neurons (Oldfield et al.,
2002) suggests that the hyperthermia triggered by MCR stimulation of RCh involves
BAT thermogenesis. Other mechanisms, may also contribute to the observed
hyperthermia. Neither skin temperature nor vascular resistance changes were
measured here and as such vasoconstriction remains a possible mechanism contributing
to the increasing core temperature response to central by melanocortinergic stimulation.
In fact, studies employing neuroexcitation (chemical and electrical) of the RVLM show
that thermoregulatory effects are associated with changes in sympathetic activity to
vasculature (specifically tail vein) rather than to changes in BAT thermogenesis
(Morrison, 1999; Ootsuka and McAllen, 2005). Here, we showed that MCR stimulation
of RVLM increased core temperature. Therefore it will be important to consider whether
a given effect of MCR stimulation– e.g., hyperthermia – can arise from distinct MC4Rbearing nuclei via separable and distinct physiologic effectors. We noted above that the
hyperthermic effect observed for NTS stimulation may result from a BAT-mediated
output, whereas the hyperthermic effect following RVLM stimulation may be mediated
by SNS control of the vasculature. Consistent with this view is data showing that SNS
output to certain tissues can be differential with potentially different output circuitries
reaching different tissues (Morrison, 1999; Rathner and McAllen, 1999; Morrison,
2001a, b).
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Tachycardia
MTII stimulation of both hindbrain and hypothalamic nuclei elicited a marked
and long-lasting tachycardia. The 5pmol MTII dose was effective in triggering this
response from PVN, PBN, RVLM and NTS sites. The same dose was of varying
effectiveness in inducing thermogenesis possibly implicating a higher sensitivity of the
tachycardic response. All MTII stimulated tachycardic responsive areas in this study are
directly or indirectly connected to autonomic outflow to the heart (Ter Horst et al., 1996;
Ter Horst and Postema, 1997). A role for RVLM in cardiovascular control is well
established; sympathoexitatory RVLM neurons project directly to intermediolateral cell
column (IML) (Brown and Guyenet, 1985; Guyenet et al., 1996). MCR stimulated
tachycardia from RVLM is likely mediated by the increased sympathetic nerve activity.
Support for this interpretation comes from a study showing that RVLM injection of
ACTH (with affinity for MC1-5R; greatest affinity for MC2R) in anesthetized rats
increases sympathetic nerve activity, blood pressure and HR (Kawabe et al., 2006). The
greater magnitude (2-3 fold larger) and duration (10 times longer; 20 min vs. 6h) of the
HR effect in our study is likely attributable to the greater affinity of the agonist used
(MTII vs. ACTH) and the behavioral state of rats. The tachycardic effect we report for
NTS stimulation is not consistent with the direction of the effect – bradycardia –
reported for ACTH injection into NTS at the area postrema level of anesthetized rats
(Brown et al., 2006). The same group of investigators however showed that injections of
SHU 9119 (MC3/4R antagonist) also produces bradycardia in anesthetized rats,
potentially blocking the effects of endogenously released melanocortin agonist. A role
for the PBN in cardiovascular regulation is well established. Electrical or chemical
stimulation of PBN elicits tachycardia via RVLM projections and subsequent SNS premotor neuron activation (Mraovitch et al., 1982; Miura and Takayama, 1991; Agarwal
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and Calaresu, 1993). Melanocortinergic stimulation of the PBN induced a small
magnitude but statistically significant tachycardia; this is the first report of a direct
effect on HR of melanocortins in PBN.

Spontaneous locomotor activity
Activity can be a contributing factor to the pathogenesis of obesity. Decreases in
spontaneous activity are strongly correlated with obesity development and fat pad
deposition (Castaneda et al., 2005). While little is known about the neural basis of this
response, available evidence implicates many of the neuropeptides associated with food
intake in the control of physical activity. Central (ventricular) MTII stimulation
increases and antagonist (AgRP) application decreases spontaneous locomotor activity
in rats (Hwa et al., 2001; Tang-Christensen et al., 2004; Koo et al., 2008). Our study
suggests that MCR-bearing neurons of the PVN and PBN contribute to this effect of
MTII, as low, picomolar doses of MTII in these nuclei increased physical activity.

Food intake
The NTS, RCh, PVN, and PBN are among the nuclei most prominently
implicated in the neural control of food intake. The anorexia shown here after MTII
delivery to NTS and PVN is consistent with the results of other publications (Giraudo et
al., 1998; Williams et al., 2000a; Wirth et al., 2001). The anorexia induced by picomolar
MTII dose delivered to PBN and RCh is the first such report. The size of the anorexic
effect from these sites (~5g over the18 h measurement) is comparable to that observed
after PVN and NTS stimulation. It is important to note that the experimental design
employed here, however, only captures food intake effects of a longer term nature (6 h24 h post drug injections). It is entirely possible that the magnitude and temporal
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pattern of the effect on food intake would differ across these sites if food had been
available and intake measured during the initial post-injection period (1-6 h post drug).

The energy balance effects reported here arise from the exogenous stimulation of
a number of anatomically disparate sites and lead naturally to a consideration of the
endogenous melanocortin system and its role in normal physiology. One important but
unresolved question is the source of the endogenous agonist for the hypothalamic and
hindbrain sites investigated. Two populations of POMC neurons, one in hypothalamic
ARC and the other in hindbrain NTS, are the sources of endogenous α-melanocyte
stimulating hormone (α-MSH). Some MCR-bearing nuclei are innervated by one of
those populations but others might have dual innervation. Until recently this problem
has not been adequately explored. Berthoud et al. (Berthoud HR, 2008) showed that
MC4R-bearing NTS neurons receive a majority (~70%) of their α-MSH input from the
hypothalamic arcuate POMC population but some (~ 30%) originate locally from the
NTS POMC neurons (Berthoud HR, 2008). This result is consistent with a suggestion by
Palkowitz et al (Palkovits et al., 1987) that hypothalamic α-MSH fibers might provide a
majority of the innervation for the midline hindbrain nuclei like NTS and medullary
raphe whereas the more lateral MCR expressing hindbrain regions (e.g. RVLM) might
receive a greater percentage of their innervation from NTS α-MSH fibers. The PVN and
RCh receive projections from ARC POMC neurons (Joseph and Michael, 1988) but NTS
α-MSH projections to these areas have not been extensively studied and cannot be ruled
out (see (Sim, 1994; Sim and Joseph, 1994). The PBN receives input from the
commissural NTS (Sim, 1994; Sim and Joseph, 1994) and from the ARC (Joseph and
Michael, 1988) however more remains to be done in determining the neurochemical
phenotype of the PBN-projecting ARC and NTS neurons. Given that ARC and NTS
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POMC neurons might receive a different set of inputs, the MCR-bearing target nuclei
that receive projections from both POMC sources would logically integrate a wider range
of information.

It remains to be determined how the melanocortinergic tone (i.e. activation of
POMC neurons leading to α-MSH ligand release onto target nuclei) may be altered
under specific environmental changes e.g. fasting, high-fat diet maintenance, cold
challenge, infection etc. One approach to addressing these questions would be to block
endogenous melanocortin signaling in a given nucleus through the use of site-specific
receptor antagonist or via viral knockdown of a given melanocortin receptor. Garza et al
(Garza et al., 2008) used RNAi technology to show that MC4R signaling in PVN is
necessary for the regulation of food intake and body weight regulation under unique
circumstances (energy expenditure not measured). The hyperphagia and obesity was
observed only when rats were maintained on high-fat food; PVN MC4R knockdown rats
maintained on chow were normophagic. The results suggest that the high-fat feeding
alters endogenous melanocortinergic tone where normal MC4R function keeps high-fat
induced hyperphagia in check.

It will be useful to determine the neurochemical phenotype of the MTIIstimulated neurons. Such detail could provide insight into the downstream pathways
and help to better define the neurocircuitry mediating melanocortinergic effects. For
example, in considering MCR function for NTS neurons it has become apparent that
some MC4Rs are located presynaptically on vagal afferent terminals indicating that
melanocortin signals are likely interacting with the vagal transmission to influence the
excitability of NTS recipient neurons (Wan et al., 2008). This modulation could indicate
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a potential mechanism for the anorexic effect of NTS MTII stimulation where vagal
signals arising from e.g. gastric distention or CCK stimulation could be enhanced by
MC4R activation leading to a more potent decrease of food intake than that induced by
vagal activation alone (Wan et al., 2008). In the PVN, Mountjoy et al.(Mountjoy et al.,
1994) report that high concentrations of the MC4R mRNA are found in both the
parvocellular and magnocellular neurons, indicating the potential of central (e.g.
sympathetic) as well as neuroendocrine mediation of MC4R stimulation effects in this
nucleus. PVN thyrotropin-releasing hormone (TRH) expressing neurons are densely
innervated by melanocortin fibers and central intake, thermogenic and cardiovascular
effects of TRH are similar to those of MC4R stimulation (Lechan and Fekete, 2006)
making this neuropeptide a potential mediator of some of the observed effects of
melanocortin signaling. Oxytocin is also expressed in the parvocellular PVN neurons
that influence BAT function (Oldfield et al., 2002), however interaction of melanocortin
with oxytocin has been mainly indicated at the magnocellular division of PVN
(Caquineau et al., 2006), leaving mediation of effects by oxytocin expressing neurons
unclear. In PBN MC4R are expressed on neurons that are activated (expression of c-fos
mRNA) by lipopolysaccharide or lithium chloride treatment and potentially project from
the external lateral PBN to the amygdala, relaying to the forebrain information of
relevance to certain aspects of sickness behavior (Paues et al., 2006).

The current data are consistent with the hypothesis that different aspects
of energy balance control can be elicited by melanocortin ligand stimulation of a single
MCR-bearing nucleus. It remains to be determined, however, whether the same neurons
within each nucleus relay signals pertaining to all relevant parameters, e.g., intake,
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thermogenesis and tachycardia or whether different sub-populations of neurons relay
information pertaining to each output parameter separately.

Our results show that there is a certain degree of redundancy in the organization
of the central melanocortin system, since the same responses can be obtained by
stimulation of anatomically disparate MCR-expressing neurons. This idea of
redundancy (Grill and Kaplan, 2002) is strengthened by the fact that rats with
electrolytic PVN lesions show melanocortin-induced anorexia identical to that of
controls (Dube et al., 2006) indicating that other MCR populations can be utilized when
one is rendered dysfunctional. Although focal PVN MCR stimulation (as shown in the
current data) induced energy balance effects it is not necessary for the physiological
MCR output as shown in the PVN lesion result just noted. Redundancy of function can
have interesting implications for our understanding of the CNS control of energy
balance. For example characterizing changes in MCR expression in one area of the brain
is no longer sufficient for indicating a physiological change in behavior, given the
presence of other brain regions that could still mediate the MCR effect with the end
result of unaltered physiological outcome (Munzberg et al., 2004; Munzberg et al., 2005;
Skibicka and Grill, 2009b). Future studies should therefore benefit from extending
their focus to a more distributed melanocortin system when evaluating control of energy
balance.
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Figure 3.1: Effect of MTII stimulation of nucleus of the solitary tract (NTS) MCRs
on (A) core temperature (TC), (B) heart rate (HR), (C) spontaneous activity in rats. Line graphs
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represent across-rat average parameter measurements through the recording period. The
bracketed time period on the line graph x-axis indicates the periods used in the adjacent
histograms, which provide 6 h post-injection averages + SEM for each parameter at each dose.
Effect of NTS MTII injection on 24 h food intake (D) and 24 h change in body weigh (E) in awake,
non-anesthetized rats. Food was made available to animals 6 h after injections and through the
12 h period of the dark cycle. Histograms represent means + SEM. *P < 0.05, **P < 0.005, ***P <
0.0005. (F) Representative NTS injection site (indicated by the arrow). 4V, fourth ventricle; Sol,
nucleus of the solitary tract; SolIM, intermedial nucleus of the solitary tract. All following figures
presented in this chapter will have a similar format; the principal variable is the site of
parenchymal site of injection of MTII.
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Figure 3.2: Effect of MTII stimulation of rostral ventrolateral medulla (RVLM)
MCRs on TC (A), HR (B), spontaneous activity (C), 24-h food intake (D), and 24-h change in
body weight (E). (F) Representative RVLM injection site (indicated by the arrow). 4V, fourth
ventricle; SolIM, intermedial nucleus of the solitary tract; Amb, nucleus ambiguus.
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Figure 3.3: Effect of MTII stimulation of parabrachial nucleus (PBN) MCRs on TC
(A), HR (B), spontaneous activity (C), 24-h food intake (D), and 24-h change in body weight (E).
(F) Representative PBN injection site (indicated by the arrow). LPBV, lateral parabrachial
nucleus ventral; LPBE, lateral parabrachial nucleus external; LPBC, lateral parabrachial nucleus
central; MPBE, medial parabrachial nucleus external; scp, superior cerebellar peduncle.
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Figure 3.4: Effect of MTII stimulation of paraventricular nucleus (PVN) MCRs on
TC (A), HR (B), spontaneous activity (C), 24-h food intake (D), and 24-h change in body weight
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(E). (F) Representative PVN injection site (indicated by the arrow). PaPo, paraventricular
nucleus posterior part; PaMP, paraventricular nucleus medial parvicellular; LH, lateral
hypothalamus; AHA, anterior hypothalamic area; VMHA, ventromedial hypothalamus anterior;
opt, optic tract.
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Figure 3.5: Effect of MTII stimulation of retrochiasmatic area (RCh) MCRs on TC (A),
HR (B), spontaneous activity (C), 24-h food intake (D), and 24-h change in body weight (E). ). (F)
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Representative PVN injection site (indicated by the arrow). AHC, anterior hypothalamic area
central; AHP, anterior hypothalamic area posterior; opt, optic tract; 3V, third ventricle.
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Figure 3.6: Effect of MTII stimulation of anterior hypothalamic area (AHA) MCRs
on TC (A), HR (B), spontaneous activity (C), 24-h food intake (D), and 24-h change in body
weight (E).
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CHAPTER 4
HINDBRAIN LEPTIN STIMULATION INDUCES ANOREXIA AND
HYPERTHERMIA MEDIATED BY HINDBRAIN MELANOCORTIN3
RECEPTORS

ABSTRACT
Of the CNS receptors that could mediate the energy balance effects of leptin those of the
hypothalamic arcuate nucleus receive the greatest attention. Melanocortin receptors
(MCRs) contribute to the feeding and energetic effects of hypothalamically delivered
leptin. Energy balance effects of leptin are also mediated by extra-hypothalamic
neurons including the hindbrain nucleus tractus solitarius. Hindbrain leptin receptors
play a role in leptin’s anorectic effects but their contribution to its energetic effects and
their functional interaction with melanocortin systems within the hindbrain remains
unexplored. Here, rats implanted with telemetric devices for recording
energetic/cardiovascular responses were examined to determine whether: 1) hindbrain
(4th ventricular; v) leptin receptor stimulation triggers energetic and cardiovascular
effects, 2) these effects are altered by a 6 week high-fat diet maintenance, and 3)
hindbrain MCRs mediate the thermogenic, cardiovascular and anorexic effects of
hindbrain leptin delivery. Results show that hindbrain leptin receptor stimulation
produced long-lasting (>6h) increases in core temperature and heart rate and also
decreased food intake and body weight. These responses were not altered by high-fat
maintenance; in contrast to what has been reported for forebrain leptin delivery. Fourth
v pretreatment with MCR antagonist SHU 9119 completely abolished the hyperthermia,
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anorexia and body weight loss seen with hindbrain-directed leptin but had no effects of
its own. These data highlight a role for hindbrain leptin receptors in the initiation of
energetic and anorexic responses and show that MCRs are part of the downstream
mediation of hindbrain leptin-induced energy balance effects, paralleling effects
observed for hypothalamic leptin receptors.

INTRODUCTION
Disruption in central nervous system (CNS) leptin signaling results in severe
obesity (Pelleymounter et al., 1995). Exogenous leptin delivery reverses the hyperphagia
and reductions in activity, metabolism, and body temperature that contribute to the
obesity observed in ob/ob mice (Halaas et al., 1995; Pelleymounter et al., 1995; Halaas
and Friedman, 1997). Central leptin receptors mediate these energy balance effects
(Elmquist et al., 1997). Although leptin receptors (Ob-Rbs) are anatomically distributed
across nuclei in the basal forebrain, midbrain and hindbrain of relevance to energy
balance control (Elmquist et al., 1998), the literature is dominated by a focus on the role
of ObRb-bearing arcuate hypothalamic neurons. Recent experiments establish
contributions to the control of energy intake from leptin signaling in the ventromedial
hypothalamus (Dhillon et al., 2006), ventral tegmental area (Hommel et al., 2006) and
nucleus tractus solitarius (NTS) (Huo et al., 2007). The neural mediation of leptin’s
energy expenditure effects receives considerably less attention than its energy intake
effects (Hermann et al., 2006), yet the focus here too is on hypothalamic leptin signaling
(Rahmouni and Morgan, 2007). This paper addresses the contribution of caudal
brainstem leptin receptors in mediating the energetic effects of leptin.
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The energy balance effects of basal forebrain-directed, third ventricular (3rd v)
leptin delivery are mediated, in part, by downstream effects on hypothalamic
proopiomelanocortin (POMC) neurons and melanocortin receptors (MC-Rs) (Seeley et
al., 1997; Satoh et al., 1998; Haynes et al., 1999). This perspective is supported by
experiments that show that: leptin signaling in these neurons increases POMC gene
expression (Schwartz et al., 1997; Elmquist, 2001) and pretreatment with MC-R
antagonist attenuates the anorexic effects, as well as some of the sympatheticallymediated energetic effects of 3rd v leptin delivery (Seeley et al., 1997; Haynes et al., 1999).
Therefore, a second aim of this paper was to examine whether caudal brainstem MC-Rs
and NTS POMC neurons contribute to the energy balance effects triggered by leptin
signaling in the caudal brainstem.

High-fat (HF) diet feeding in rodents and humans results in obesity,
hyperleptinemia, resistance to the effects of exogenous leptin and insulin delivery and
glucose intolerance (Gleason et al., 2007; Myers et al., 2008). Leptin resistance is
characterized by a decreased sensitivity to the anorexic and body weight effects of leptin
(Myers et al., 2008). As noted above, there is a developing consensus that the effect of
leptin on energy balance is mediated by several brain nuclei. By contrast, the
neuroanatomical basis of leptin resistance is less clear. Leptin resistance may result
from alterations in leptin signaling across several CNS sites or by contrast may be
attributable to specific populations of Ob-Rb expressing neurons in the CNS (Munzberg
et al., 2004; Enriori et al., 2007). A variety of experimental evidence is consistent in
revealing that forebrain ventricular delivery of leptin results in diminished hypophagia
in rats maintained on HF diet than in chow-maintained controls (Widdowson et al.,
1997; Tulipano et al., 2004; Fam et al., 2007). While it is generally assumed that
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hypothalamic Ob-Rb expressing neurons are the principal target of forebrain ventricular
delivery, it is unclear whether other ObRb-expressing nuclei accessed by this injection
also contribute to the reduction in response magnitude observed in HF-diet maintained
rodents. Unexamined, are the effects of HF-diet maintenance on the hypophagia to
hindbrain ventricular delivery of leptin. It also remains to be determined whether some,
but possibly not all, responses induced by central leptin delivery are attenuated by HFdiet maintenance as sympathetic nervous system (SNS) activation is observed in leptintreated animals that are otherwise leptin resistant (Rahmouni et al., 2002; Rahmouni et
al., 2008). For these reasons we pursue the functional consequences of high-fat diet
maintenance on the energy intake, as well as energy expenditure responses triggered by
hindbrain-delivered, 4th ventricle leptin.

Collectively, the results described here establish a role for hindbrain Ob-Rb in
mediating elevations in core temperature and heart rate. These energetic and
cardiovascular responses, as well as anorexic and body weight responses triggered by
hindbrain leptin delivery were found to be unaltered in rats fed high-fat diet. In addition,
our studies provide support for the hypothesis that hindbrain MC-Rs are downstream
mediators of hindbrain leptin-induced energetic and anorexic responses.

METHODS

Subjects: Male Sprague-Dawley rats (Charles River Laboratories, Wilmington, MA),
weighing 300–400 g at the time of surgery, were housed individually in plastic bins, and
maintained under a 12:12-h (8.00am lights on) light-dark cycle. Pelleted food (Purina
5001; St. Louis, MO) and water were available ad libitum unless otherwise noted. All
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procedures conformed to the institutional standards of animal care and use (University
of Pennsylvania).

Surgery: Rats were anesthetized with ketamine (90 mg/kg), xylazine (2.7 mg/kg), and
acepromazine (0.64 mg/kg) delivered intramuscularly.

4th intracerebroventricular cannulation. All rats received a fourthintracerebroventricular (4th v) guide cannula (Plastics One, 22-G) with its tip
stereotaxically positioned 2.0 mm above the 4th v (coordinates: on the midline, 2.5 mm
anterior to the occipital suture, and 4.5 mm ventral to the dura, with injector aimed 6.5
mm ventral from dura). Cannulas were attached to the skull with dental acrylic and
jeweler's screws and closed with an obturator.

Telemetric transponder surgery: At the time of ventricular surgery, telemetric
transponders (HRC 4000 Mini-Mitter, VitalView, OR) for recording core temperature
(Tc), heart rate (HR) and spontaneous physical activity (SPA) were inserted into the
abdominal cavity, external leads were positioned subcutaneously, and secured to the
muscles on either side of the heart with sutures [as previously described (Skibicka and
Grill, 2008b)].

Experimental procedure

Cannula position verification. At least 7 days after surgery, 4th v cannula placement was
assessed by measurement of the sympathoadrenal mediated hyperglycemic response to
the cytoglucopenia induced by 5-thio-D-glucose [210 µg in 2 µl of artificial cerebral
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spinal fluid (aCSF)] (Ritter et al., 1981). A post-injection elevation of at least 100% of
baseline glycemia was required for subject inclusion.

Habituation training. Prior to the start of experimental testing, rats were acclimated to
handling, 4th v injections, and gastric gavages for oral glucose tolerance tests (OGTT)
testing.

Food intake and body weight monitoring: Food was removed 1 h before treatment (1 h
into the light cycle) and returned 8 h later, late in the light phase. Thereby, food was not
available during the period of energetic response measurement as feeding can affect
these responses. Food intake and body weight measurements were made 24 h after the
injection of drug. Food was available during the dark cycle and a minimum of 48 h was
allotted between experimental testing.

Experiment 1: Effects of 4th v leptin delivery on energy expenditure and food intake
in chow-fed and high fat-fed rats.

Feeding maintenance: Rats were randomly assigned to standard chow (n=8) or HF diet
[(Research Diets #D12266B, New Brunswick, NJ, USA; 4.47 kcal/g with 21% of the
metabolizable energy content as protein, 31% as fat and 48% as carbohydrate), (n=16)]
maintenance one week after surgery. All testing began after five weeks of maintenance
on the respective diets. Food intake and body weight of all rats were monitored daily.
The physiological alterations induced by HF-diet maintenance are well established and
include hyperleptinemia-leptin resistance and hyperinsulinemia-insulin resistance [see
for review (Gleason et al., 2007; Myers et al., 2008)]. The OGTT was administered
before HF exposure and 1, 4 and 5 weeks after diet maintenance to provide one correlate
of the physiological effects of HF diet maintenance. Food was withheld for a 6-h period

79

(with access to water) during the first half of the light cycle; an oral glucose load (2 g/kg)
was delivered to each rat by gavage. Blood glucose was measured before gavage and at
30, 60, 90, 120 and 180 min post-glucose loading by collecting a drop of tail blood and
placing it in a standard glucometer strip (Accucheck, Roche Diagnostics, Indianapolis,
IN).

Experimental testing: All rats received 4th v injections early in the light cycle. Due to the
caudal flow of the cerebral spinal fluid, low volume injections through the 4th v cannula
under specific experimental conditions provide selective stimulation of hindbrain CNS
regions without affecting hypothalamic and other forebrain regions as shown by: (Flynn
and Grill, 1985; Kinzig et al., 2002; Blevins et al., 2004; Fan et al., 2004). Three
conditions were run in a counterbalanced fashion across separate days. Energetic
responses were examined in chow- and HF-fed rats following a control condition with
4th v vehicle (1 µl sodium bicarbonate) and two doses of leptin: 3 and 10 µg [dose
selection based on (Widdowson et al., 1997; Levin and Dunn-Meynell, 2002; Tulipano
et al., 2004)]. HR, TC, and SPA were continuously monitored for 8 h at 5-min intervals
(Tc and SPA) or 30-sec intervals (HR) in rats with implanted HRC-4000 transponders.

Experiment 2: Effect of hindbrain- delivered MC-R antagonist on the energy balance
effects of leptin delivered to hindbrain. All rats (n=9) received 4th v injections early in
the light cycle. All conditions were separated by 2 days and run in a counterbalanced
fashion. Responses were examined after four conditions as follows: 1) control condition
with 4th v vehicle [1 µl of aCSF (vehicle for MC3/4-R antagonist - SHU 9119) with 1 µl of
sodium bicarbonate (vehicle for leptin)], 2) aCSF +3 µg leptin, 3) 0.1 nmol SHU 9119 +
sodium bicarbonate and 4) SHU 9119 with leptin. SHU 9119/vehicle was injected 20
minutes before leptin/vehicle treatment. SHU 9119 dose was selected from results of a
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pilot study that tested the efficacy of SHU doses in blocking the energy balance effects of
4th v MC-R agonist (MTII; Phoenix Pharmaceutical, St Joseph, MO) without producing
any independent effects alone. HR, TC, and SPA were continuously monitored as in
Experiment 1.

Statistical analysis. All energy expenditure parameters were analyzed by one or twoway ANOVAs on 6 h post-injection averages and followed by post-hoc t-tests and
Tukey’s honestly significant difference test as appropriate. Twenty-four h food intake
and body weight were analyzed by ANOVA followed by post-hoc t-tests and Tukey’s
honestly significant difference test as appropriate. All statistical analysis was conducted
using Statistica software (Tulsa. Oklahoma). Differences were considered significant at
P<0.05.

RESULTS:

Experiment 1. Stimulation of hindbrain Ob-Rb increases energy expenditure and
decreases food intake in chow- and high-fat fed rats:

Chow- fed group: Core temperature: Figure 4.1a shows that hindbrain-delivered leptin
injection increased TC for the 6 h post-injection period. A one-way ANOVA examining
treatment effects on average post-injection TC values revealed a significant drug
treatment effect [F (2, 10) = 13.89, P < 0.005]. Post hoc analysis showed a significant
effect of both leptin doses on TC (3 µg; P < 0.005, 10 µg: P < 0.005). Heart rate: Figure
4.1b shows that leptin increased HR, compared with control treatment. A one-way
ANOVA of average HR values for the 6 h post-injection period yielded a significant drug
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effect [F (2, 10) = 6.40, P < 0.05); post hoc analysis showed a significant effect of the
lower dose of leptin on HR (3 µg; P < 0.05, 10 µg: P < 0.323). Spontaneous physical
activity was not significantly increased by leptin treatment [F (2, 10) = 1.79, P =0.216;
Figure 4.1c]. Food intake and body weight: Fourth ventricle injection of leptin
significantly decreased 24 h food intake [F (2, 14) = 6.883, P < 0.01; post hoc: 3 µg; P <
0.28, 10 µg: P < 0.05] and body weight [F (2, 14) = 4.155, P < 0.05; post hoc: 3 µg; P <
0.82, 10 µg: P < 0.05] (Figure 4.2a & b).

High-fat fed group: Oral glucose tolerance tests were performed prior to HF-diet
exposure [area under the curve ± SE: 315.4 ± 15.8 chow-fed (CH) vs. 320.3 ± 7.4 high fat
(HF)] and after 1 week (CH: 312.6 ± 16.2 vs. HF: 312.9 ± 5.5), 4 weeks (CH: 313.1 ± 8.9
vs. HF: 348.6 ± 6.5± 8.9) and 5 weeks (CH: 316.7 ± 8.0 vs. HF: 361.7 ± 6.4) on HF diet
maintenance in comparison to chow-fed control rats. High-fat fed animals showed
impairment in glucose clearance relative to chow-fed control rats after 4 weeks (P <
0.005) and 5 weeks (P < 0.0005) of high fat exposure. All rats on HF diet showed
reduced glucose clearance after 5 weeks on HF diet; therefore all were included in the
energy expenditure analysis. Core temperature: Figure 4.3a shows that 4th v injection of
each dose of leptin increased TC for the 6 h post injection period. A one-way ANOVA
examining treatment effects on average post-injection TC values yielded a significant
drug treatment effect [F (2,28) = 7.00, P < 0.005]. Post hoc analysis revealed a
significant effect of both leptin doses on TC (3 µg; P < 0.01, 10 µg: P < 0.01). Heart rate:
Figure 4.3b shows that leptin increased HR, compared with the aCSF vehicle treatment.
A one-way ANOVA of average HR values for the 6 h period post-injection yielded a
significant drug effect [F (2,28) = 5.47, P < 0.01]; post hoc analysis showed a significant
effect of both doses of leptin on HR (3 µg; P < 0.05, 10 µg: P < 0.05). Spontaneous
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physical activity was not significantly increased [F (2, 28) = 0.029, P = 0.972] by leptin
treatment (Figure 4.3c). Food intake and body weight: Both leptin doses significantly
decreased 24 h food intake [F (2, 30) = 18.79, P < 0.0001; post hoc: 3 µg; P < 0.0005, 10
µg: P < 0.0005] and body weight [F (2, 30) = 13.75, P < 0.0001; post hoc: 3 µg; P <
0.0005, 10 µg: P < 0.0005] (Figure 4.4a & b). Between-group comparisons (chow-fed
vs. high-fat fed) were made for all parameters. No significant differences in TC, HR, SPA
and food intake of chow- and high-fat fed groups were found for any doses. Body weight
responses were significantly different at the 0 µg and 10 µg doses, but when responses
were expressed as change from vehicle no significant differences were found.

Experiment 2: Hindbrain- delivered MC-R antagonist blocks the energy balance
effects of hindbrain leptin delivery. Hindbrain pretreatment with a MC-R antagonist
reversed the effects of 4th v leptin treatment on energetic/cardiovascular responses, food
intake and body weight, but was without effects on its own (Figures 4.5 & 6). Core
temperature: Figure 4.5a shows that the leptin-induced increase in TC for the 6 h post
injection period was reversed by pretreatment with the MC-R antagonist SHU 9119. A
two-way ANOVA examining the interaction of leptin and SHU 9119 on average postinjection TC values revealed a significant interaction [F (1, 8) = 9.25, P < 0.05]. Post hoc
analysis revealed a significant effect of only leptin alone on TC (3 ug; P < 0.05) compared
to vehicle. The leptin + SHU 9119 condition was not significantly different from vehicle
(P = 0.88). Heart rate: Figure 4.5b shows that there was a trend for leptin to increase
HR although the effect was not significant compared with the control treatment. A oneway ANOVA of average HR values for the 6 h post-injection period yielded a significant
drug effect [F (3, 24) = 3.714, P < 0.05]; post hoc analysis showed a trend for leptin to
increase HR (3 µg; P < 0.078), but SHU 9119 pretreatment attenuated the effect of
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leptin on HR (P = 0.999). A two-way ANOVA of average HR values for the 6 h postinjection period examining the interaction of leptin and SHU 9119 did not reach
significance [F (1, 8) = 2.61, P = 0.14]; Spontaneous physical activity was not
significantly affected by leptin, SHU 9119, or their combination. There was no
significant interaction [F (1, 8) = 2.06, P = 0.19] (Figure 4.5c). Food intake and body
weight: Hindbrain-directed leptin delivery significantly decreased 24 h food intake.
Two-way ANOVA revealed significant interaction of leptin and MC-R antagonist [F (1,
8) = 7.83, P < 0.05]; post hoc Tukey tests revealed that leptin decreased food intake (P <
0.005), pretreatment with SHU 9119 blocked the effects of leptin [leptin + SHU 9119: P
= 0.97] (Figure 6a). Body weight was also significantly decreased by leptin treatment
alone, pretreatment with SHU 9119 reversed this effect [F (1, 8) = 11.55, P < 0.05; post
hoc Tukey test for leptin alone: P < 0.05, and for leptin SHU 9119: P = 0.79] (Figure
4.6b). SHU9119 application itself had no effect on any of the parameters measured.

DISCUSSION

The data gathered indicate that hindbrain leptin receptors contribute to the
energy balance effects of CNS leptin delivery. These are the first data to show that
stimulation of hindbrain leptin receptors drives thermogenic and tachycardic responses.
The hypophagia and body weight reduction also observed with hindbrain leptin delivery
confirm our earlier work in lean chow-fed rats (Grill and Kaplan). The present study
also shows that hindbrain leptin delivery in high-fat diet maintained rats with reduced
glucose clearance triggers anorexic and energetic responses of the same magnitude as
those observed in chow-fed controls. These data indicate that alterations in hindbrain
Ob-Rbs signaling do not contribute to the physiology of leptin resistance.
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A role for hypothalamic melanocortin gene expression and MC-Rs in the
downstream effects of hypothalamic leptin signaling is well established (Seeley et al.,
1997; Haynes et al., 1999). Our experiments address a parallel but neglected question –
whether hindbrain melanocortin signaling is downstream of the functional effects of
hindbrain leptin signaling. We show that hindbrain delivery of the MC3/4-R antagonist
SHU-9119 blocked the food intake, body weight and energetic responses triggered by 4th
v leptin. This pattern of results is parallel with data generated for forebrain ventricular
delivery using a similar strategy (Seeley et al., 1997; Satoh et al., 1998; Haynes et al.,
1999). Systemic leptin treatment stimulates Ob-Rs on ARC POMC neurons, induces
pSTAT3 in arcuate POMC neurons and increases POMC gene expression. These effects
are mediated by direct action of leptin on these POMC neurons. Some controversy
surrounds whether NTS POMC neurons express leptin receptors in mouse models
(Ellacott et al., 2006; Huo et al., 2006). Whether the effects observed here are mediated
by leptin receptor expression in rat NTS POMC neurons or leptin receptors on other
neurons that in turn affect NTS POMC gene expression and melanocortin ligand release
remains to be investigated.

Obesity induced by multi-week HF-diet maintenance did not reduce the
magnitude of either the anorexic or energetic-sympathetic responses elicited by
hindbrain leptin administration. These functional results are consistent with the
findings of Munzberg et al (Munzberg et al., 2004) who showed that multi-week, HF
diet maintenance did not reduce Ob-Rb signaling (pSTAT3 immunohistochemistry) in
NTS neurons or in the neurons of the ventromedial, dorsomedial or premammilary
hypothalamus [see also (Ladyman and Grattan, 2004)]. Of the brain regions sampled in
their study, an attenuation of leptin signaling with diet-induced obesity was observed
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only in the hypothalamic ARC nucleus; this reduced ARC-leptin signaling was detected
as early as 6 days after the start of HF diet feeding (Munzberg et al., 2004). While we
have not examined forebrain-directed leptin responses, others investigators have
established that lateral ventricular leptin delivery (doses overlapping with those used
here) in rats made obese with HF feeding (Widdowson et al., 1997; Tulipano et al.,
2004) or in obese aged rats (Shek and Scarpace, 2000) result in markedly attenuated
food intake and body weight effects of leptin. These examples of attenuated functional
effects of leptin delivered to the forebrain ventricles of rats with some degree of leptin
resistance contrast with what we observed in similarly maintained rats receiving 4th v.
leptin. These contrasting data sets suggest that specific CNS Ob-Rb expressing regions
respond differently to the obesity resulting from high-fat diet maintenance and also that
lack of alterations in NTS leptin signaling (Munzberg et al., 2004) correlate with
preserved effects on feeding and energy expenditure. Hindbrain Ob-Rbs, due to their
lack of molecular and functional leptin resistance, might therefore account for the
preserved SNS activation observed after peripheral leptin injections in animals
otherwise leptin resistant (Rahmouni et al., 2002; Rahmouni et al., 2008). Ob-Rbs in
the hindbrain might also contribute to partial anorexic responses observed after lateral
ventricle leptin application, since the drug can diffuse with the caudal CSF flow and
stimulate ObRb-expressing hindbrain neurons.

Our studies focus attention on the functional effects of hindbrain leptin receptors
and, in addition, identify a downstream mediator of these effects, POMC neurons and
hindbrain melanocortin receptors. Furthermore, our data along with findings by
Munzberg et al (Munzberg et al., 2004) suggest that this hindbrain projection pathway
may, unlike its hypothalamic counterpart, be less subject to the effect of the reduction in
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leptin signaling observed with diet-induced obesity. The details of the mediating neural
circuitry however still remain to be delineated. Neurons of the NTS and parabrachial
nucleus (PBN) express OB-Rbs (Elmquist et al., 1998) and contribute to the control of
feeding behavior and to sympathetic outflows (Grill and Kaplan, 2001; Cano et al.,
2003a). We have recently conduced studies employing targeted leptin delivery to NTS as
well as PBN are to resolve this issue. Direct application of leptin into the NTS resulted in
an energetic a feeding profile of responses similar to that obtaiend with 4th v leptin
delivery. Thus it is likely that the energetic and part of the anorexic responses observed
here reflect NTS Ob-Rb stimulation (Figures 4.7-4.8). Parabriachial Ob-Rb stimulation
on the other hand did not alter body temperature or heart rate, however produced
hyperactivity, anorexia and body weight loss (Figures 4.9-4.11). These are the first data
indicating a role for PBN Ob-Rb in energy balance control. Results from our current
studies do not exclude the possibility that projections to forebrain neurons are required
for response production. Little is known about the neurochemical phenotype and
anatomic projections of Ob-Rb-expressing hindbrain neurons. NTS neurons are known
to project to hypothalamic neurons including those in ARC and paraventricular
hypothalamus. NTS neurons may project to POMC-expressing ARC neurons, that in
turn, project back to the NTS to provide for the release of MC ligand in the NTS from a
hypothalamic origin (Palkovits et al., 1987; Berthoud HR, 2008). The requirement for
forebrain-hindbrain neural communication for leptin-induced increases in energy
expenditure might be suggested by a study of Harris et al (ref). Harris et al. show that
peripheral leptin stimulation in chronic decerebrate rats, that lack neural forebrainhindbrain communication, does not increase energy expenditure; in fact a decrease in
oxygen consumption in these rats is noted under certain experimental conditions. On
the other hand in its simplest form, the mediating circuitry may be placed entirely
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within hindbrain with circulating leptin stimulating hindbrain Ob-Rbs, which could in
turn activate hindbrain POMC and MC-Rs, yielding behavioral and autonomic
responses. We have already shown (Skibicka and Grill, 2008a) that the circuitry
required for melanocortin receptor stimulation-induced hyperthermia and tachycardia
is contained entirely within the hindbrain. Future experiments are needed to determine
whether the neural link from hindbrain leptin to hindbrain melanocortin receptors is
contained entirely within the hindbrain or whether the connection is mediated by
circuitry involving forebrain neurons.
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Figure 4.1: Effect of caudal brainstem leptin receptor stimulation (1 µl, 4th v. delivery)
on (a) core temperature, (b) heart rate and (c) spontaneous activity in chow fed rats. Line
graphs represent across-rat average parameter measurements through the 8 h-recording period.
The bracketed time period on the line graph x-axis indicates the periods used in the histograms.
The histograms provide 6 h post-injection averages + SEM for each parameter at each dose. *P <
0.05, **P < 0.005, n=6.
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Figure 4.2: Effect of caudal brainstem leptin receptor stimulation (1 µl, 4th v. delivery)
on (a) food intake and (b) body weight in chow fed rats. The histograms provide average
values ± SEM. *P < 0.05, **P < 0.005, n=8.
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Figure 4.3: Effect of caudal brainstem leptin receptor stimulation (1 µl, 4th v. delivery)
on (a) core temperature, (b) heart rate and (c) spontaneous activity in high-fat fed rats. Line
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graphs represent across-rat average parameter measurements through the 8 h recording period.
The bracketed time period on the line graph x-axis indicates the periods used in the histograms.
The histograms provide 6 h post-injection averages + SEM for each parameter at each dose. *P <
0.05, ***P < 0.0005, n=15.
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Figure 4.4: Effect of caudal brainstem leptin receptor stimulation (1 µl, 4th v. delivery)
on (a) food intake and (b) body in high-fat fed rats. The histograms provide average values
±SEM. *P < 0.05, ***P < 0.0005, n=16.
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Figure 4.5: Effect of caudal brainstem melanocortin receptor blockade (1 µl, SHU
9119, 4th v. delivery) on caudal brainstem leptin receptor stimulation (1 µl, 4th v.
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delivery) on (a) core temperature, (b) heart rate and (c) spontaneous activity in chow fed rats.
Line graphs represent across-rat average parameter measurements through the 8 h recording
period. The bracketed time period on the line graph x-axis indicates the periods used in the
histograms. The histograms provide 6 h post-injection averages + SEM for each parameter at
each dose. *P < 0.05, **P < 0.005, n=9.
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Figure 4.6: Effect of caudal brainstem melanocortin receptor blockade (1 µl, SHU
9119, 4th v. delivery) on caudal brainstem leptin receptor stimulation (1 µl, 4th v.
delivery) on (a) food intake and (b) body in chow fed rats. The histograms provide average
values ±SEM. *P < 0.05, **P < 0.005, n=9.
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Figure 4.7: Effect of nucleus of the solitary tract (NTS) leptin receptor stimulation
(0.1 µl, unilateral NTS parenchyma delivery) on (a) core temperature, (b) heart rate and (c)
spontaneous activity in chow fed rats. For details on surgery, coordinates, placement
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confirmation, injection strategy and statistical analysis see Methods in Chapter 3. Line graphs
represent across-rat average parameter measurements through the 8 h-recording period. The
bracketed time period on the line graph x-axis indicates the periods used in the histograms. The
histograms provide 6 h post-injection averages + SEM for each parameter at each dose. ***P <
0.0005, n=9.
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Figure 4.8: Effect of nucleus of the solitary tract (NTS) leptin receptor stimulation
(0.1 µl, unilateral NTS parenchyma delivery) on (a) food intake and (b) body weight in chow fed
rats. The histograms provide average values ± SEM. *P < 0.05, **P < 0.005, n=9.
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Figure 4.9: Effect of parabrachial nucleus (PBN) leptin receptor stimulation (0.1 µl,
unilateral PBN parenchyma delivery) on (a) core temperature, (b) heart rate and (c) spontaneous
activity in chow fed rats. For details on surgery, coordinates, placement confirmation,
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injection strategy and statistical analysis see Methods in Chapter 3. Line graphs represent acrossrat average parameter measurements through the 8 h-recording period. The bracketed time
period on the line graph x-axis indicates the periods used in the histograms. The histograms
provide 6 h post-injection averages + SEM for each parameter at each dose. *P < 0.05, n=29.
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Figure 4.10: Effect of parabrachial nucleus (PBN) leptin receptor stimulation (0.1 µl,
unilateral PBN parenchyma delivery) on (a) food intake and (b) body weight in chow fed rats.
The histograms provide average values ± SEM. *P < 0.05, n=29.

102

Figure 4.11. Effect of parabrachial nucleus (PBN) leptin receptor stimulation (0.1 µl,
unilateral PBN parenchyma delivery) on the minute by minute food intake in chow fed rats.
This experiment was performed in order to evaluate the novel anorexic effect of leptin in PBN
that was initially discovered in the previous study (Figure 4.10). To focus on the intake effects,
energy expenditure was not recorded here and unlike in the previous study standard chow
(maintenance diet) was available to the rats immediately after injection. Injections took place 20
minutes before lights-out, as indicated by the arrow. X-axis indicates time of day. Intake was
recorder every minute for a period of 24 hours. The histogram provides average 24h intake
values ± SEM from the graph above. *P < 0.05, n=8.
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CHAPTER 5
HINDBRAIN MELANOCORTIN RECEPTOR BLOCKADE EFFECTS ON
HIGH-FAT DIET INTAKE AND BASELINE ENERGY EXPENDITURE

ABSTRACT
Palatable, high-fat diets induce hyperphagia that promotes positive energy balance.. The
central melanocortin system is implicated in the compensatory adjustments of food
intake and energy expenditure that are necessary to restore energy balance.
Melanocortinergic contributions to energy balance regulation involve hypothalamic as
well as hindbrain nuclei. Hypothalamic elements of this system are implicated in the
compensatory response to high-fat feeding, but also in the maintenance of energy
expenditure under baseline chow maintenance conditions. The contribution of
hindbrain melanocortin receptors (MCRs) to both of those energy balance control
responses is unexplored. Both questions are addressed here. To assess the role of
endogenous hindbrain MCR activity to the control of energy balance under normal chow
maintenance and under the energetic challenge posed by high energy diet maintenance
feeding, cardiovascular, thermogenic and activity responses were examined in rats
injected 4th ventricular (v) with the MC3/4 antagonist SHU 9119 or its vehicle.
Hindbrain MCR blockade produced hypothermia and bradycardia without any changes
in activity in chow-fed rats at baseline. The same effects on energetic-cardiovascular
responses were observed in rats maintained on medium-fat diet. In contrast, diet
maintenance differentially affected the feeding response to hindbrain MCR antagonism.
4th v SHU application increased high or medium-fat food intake and body weight but
was without effect in rats maintained on chow. The response size observed in high-fat
fed rats with 4th v delivery did not differ from that obtained with 3rd v MCR antagonist
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injections. These data indicate that endogenous hindbrain MCR activity contributes to
baseline temperature and heart rate maintenance and is required for limiting the
hyperphagia and weight gain induced by high-fat feeding, as rats fed a high-fat diet are
more sensitive to hyperphagic effects of hindbrain MCR blockade than chow fed
controls.

INTRODUCTION
Palatable, energy-dense diets are over-consumed by humans and rodent models
and the resulting hyperphagia is a primary determinant of the current obesity epidemic
(Rothwell and Stock, 1979). The hyperphagia triggered by exposure to these can be
viewed as a challenge on the energy balance. Restoring energy balance is an active
process mediated by CNS circuits that involves curbing the hyperphagia and increasing
energy expenditure (Rothwell and Stock, 1979). The central melanocortin system is an
essential contributor to energy homeostasis under baseline, chow maintenance,
conditions as indicated by severe hyperphagia, decrease in energy expenditure, and
weight gain observed in mice or rats with dysfunctional melanocortin signaling (Huszar
et al., 1997; Adage et al., 2001). Melanocortin signaling appears to also contribute to the
compensatory adjustments in energy balance that are triggered by high-energy diet
maintenance. MCRs are expressed in several CNS areas critical to energy balance
control (Kishi et al., 2003). Despite accumulating evidence that both hypothalamic and
extra-hypothalamic MCRs contribute to energy balance control (Grill et al., 1998;
Skibicka and Grill, 2008a, 2009a), a role for extra-hypothalamic MCRs in the
maintenance of baseline energy expenditure and in the energetic challenge posed by
energy-dense diet maintenance has not been explored.
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The coordinated control of energy intake and expenditure exerted by the POMC
product α-melanocyte stimulating hormone (αMSH) and the responsiveness of POMC
neurons to the metabolic signals, e.g., circulating fuels and metabolic hormones that are
altered by high energy diet overconsumption (Schwartz et al., 1997; Benoit et al., 2002;
Ibrahim et al., 2003; Jo et al., 2009) suggest that the central melanocortin system is
well positioned to make energy balance adjustments in response to alterations in energy
intake. A role for the melanocortin system in coordinating the energetic responses to
high energy diet maintenance is suggested by results from MC4R KO mouse studies
(Butler et al., 2001). These mice, hyperphagic on chow maintenance, significantly
increase (by 50%) their food intake when exposed to a moderate fat-diet (Butler et al.,
2001). Body weight, already greater than wild type controls on chow, increases further
when MC4R-deficient mice are placed on moderate-fat diet. These data suggest that
functional central MCR signaling is a critical element in curbing intake when rodents are
maintained on high-energy diets. What is unaddressed by these results is a
determination of which of the various melanocortin expressing nuclei contribute to
these energy balance adjustments. The anorexic effects of central melanocortin signaling
are often ascribed to the MCR-bearing hypothalamic nuclei, especially the
paraventricular nucleus (PVN) (Balthasar et al., 2005; Taylor et al., 2007; Garza et al.,
2008). A role for PVN MC4R signaling in the response to the high-energy diet
maintenance challenge was highlighted recently in rats with targeted MC4R knock down
in the PVN. These rats, unlike their wild-type controls showed differential response to
diet. They gained more weight when maintained on high-fat diet but not when fed
standard, low-fat chow (Garza et al., 2008).
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MC4Rs are widely expressed anatomically and accumulating evidence suggests
that the energy balance function exerted by CNS MCR signaling is anatomically
distributed with contributions from both hypothalamic and extrahypothalamic MCRs
(Grill et al., 1998; Skibicka and Grill, 2008a, 2009a). Recent data support a role for
multiple hindbrain nuclei in the feeding and energetic-cardiovascular effect of MCR
agonist stimulation (Grill et al., 1998; Skibicka and Grill, 2008a, 2009a). Reduced
feeding, thermogenic and cardiovascular responses were triggered by discrete
melanocortinergic stimulation of several hindbrain nuclei including nucleus of the
solitary tract (NTS), parabrachial nucleus (PBN) and caudal raphe (Skibicka and Grill,
2009a). Endogenous contribution of hindbrain MCRs in chow fed rats was indicated by
a hyperphagic effect of hindbrain MCR blockade with an MC3/4R antagonist (SHU 9119)
(Grill et al., 1998; Williams et al., 2000a). In the current study we investigate whether
pharmacological blockade of endogenous activity of hindbrain MCR disrupts (a) the
intake response to the high-energy diet challenge and (b) to energy expenditure control
under chow fed baseline conditions. These results are also compared to responses
obtained by forebrain (3rd v) MCR blockade.

Diet-induced thermogenesis (DIT) describes the increase in sympathetic
nervous system (SNS) activity to several organs including heart and brown adipose
tissue (Dulloo, 2002) and the resulting increase in expenditure of energy driven by the
sequential overconsumption of palatable, high-energy diets (Rothwell and Stock, 1979).
POMC neurons are implicated in the energy expenditure adjustment to caloric overconsumption and a variety of data show that hypothalamic and hindbrain sympathetic
premotor neurons co-express MCRs (Voss-Andreae et al., 2007; Song et al., 2008).
MC4R KO mice, in contrast to their wild type controls, fail to increase oxygen
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consumption in response to high-energy diet consumption (Butler et al., 2001). While
experiments needed to resolve which of the anatomically distributed MC4R expressing
nuclei contribute to this effect have not been undertaken, the field focuses on
contributions from MCR-bearing hypothalamic nuclei. The current experiments
characterize the contribution of endogenous hindbrain MCR signalling to energy
balance control (measured parameters include: feeding, thermogenesis, cardiovascular
changes and activity) under baseline, chow intake conditions and under the energetic
challenge posed by high-energy diet maintenance. This is the first study to explore the
endogenous contribution of hindbrain MCRs to energy expenditure in both the chow
and high-energy diet feeding environment.

METHODS:

Subjects
Male Sprague Dawley rats (Charles River Laboratories, Wilmington, MA), weighing
300–400g (10-12 weeks old) at surgery and housed individually in plastic bins under a
12-h light, 12-h dark cycle (0800 h lights on), participated in the five experiments
described below. Pelleted food (Purina 5001; St. Louis, MO) and water were available ad
libitum unless otherwise noted. All procedures conformed to the institutional standards
of animal care and use committee (University of Pennsylvania).

Surgery
Rats were anesthetized with ketamine (90 mg/kg), xylazine (2.7 mg/kg), and
acepromazine (0.64 mg/kg) delivered im.
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Fourth and third intracerebroventricular (v.) cannula implantation.
Rats in experiments 1 and 2 received a fourth v. guide cannula (22 gauge; Plastics One,
Inc., Roanoke, VA) with its tip stereotaxically positioned 2.0 mm above the fourth
ventricle (coordinates: on the midline, 2.5-mm anterior to the occipital suture, and 4.5mm ventral to the dura, with injector aimed 6.5-mm ventral from dura). Drug injections
to the 4th v. at volumes used in our experiments have been shown to be confined to the
hindbrain regions without stimulation of regions rostral to the 4th v. (Flynn and Grill,
1985; Blevins et al., 2004; Fan et al., 2004; Hayes et al., 2008b). A second group of rats
in experiment 2 received a third v. guide cannula (coordinates: on the midline, 2-mm
posterior to bregma, and 5.5-mm ventral to dura mater, with injector aimed 7.5-mm
ventral to dura). Cannulas were attached to the skull with dental acrylic and jeweler’s
screws, and closed with an obturator as previously described (Skibicka and Grill, 2008a,
2009b).

Telemetric transponder surgery.
Telemetric transponders (HRC 4000 VitalView; Mini Mitter/Respironics, Bend, OR) for
recording core temperature (TC), heart rate (HR), and spontaneous physical activity
(SPA) were inserted into the abdominal cavity, with the leads positioned sc and secured
to the chest muscles on either side of the heart with sutures.

Experimental procedures
Cannula position verification.
At least 7 d after surgery, all brain cannula placements were assessed by measurement of
the sympathoadrenal-mediated glycemic response to central injection of 5-thio-Dglucose [210 µg in 2 µl artificial cerebral spinal fluid (aCSF; Harvard Apparatus) for both

109

3rd and 4th v.] (Ritter et al., 1981). A post-injection elevation of at least 100% of baseline
plasma glucose level was required for subject inclusion.

Habituation training.
Before the start of experimental testing, rats were acclimated to the handling and
ventricular injection procedures used in a given experiment.

Experiment 1: We compared two groups of rats. One was maintained on the
moderate-fat (MF) diet (Research Diets, 31% fat content); the other on regular chow
(Figure 5.1A). Rats were weighed daily starting 2 days before MF diet exposure for 12
days. Both groups were tested with SHU 9119 (0.2nmol; Sigma) and vehicle in a two
condition counterbalanced design at week 1 (days 4 and 7) on the diet (Figure 5.1B).
MCR antagonist testing was planned for the first week of fat diet exposure as all prior
published data established the strongest connection between feeding and energetic
responses of MCR blockade in acute responses to fat (Butler et al., 2001; Voss-Andreae
et al., 2007). All rats received injections 2 hours into light cycle. Food was removed at
the time of injections (early in the light cycle) and returned 8 h later, late in the light
phase. Thus, in this design food was not available during the period of energetic
response measurement. Food intake and body weight measurements were made 24 h
after the injection of drug. Given this design, all noted differences in food intake reflect
longer latency effects of SHU (i.e. intake from 8–24 h after injection). For ad libitumfeeding rats, food was always available during the dark cycle.

Experiment 2: All rats (n=12 4th v, n=12 3rd v) were tested with 0.1nmol of SHU
counterbalanced with vehicle while still maintained on chow. At least 72h were allowed
to pass between injection days. The dose of SHU was chosen to not produce energetic
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and feeding effects when applied alone on chow. At least 7 days were allowed to pass
from the initial SHU test before the high-fat (HF) diet exposure. They were then
switched to HF diet for 72h (Research Diets, 64% fat content); during that time all rats
received daily injections (at 0, 24, 48h of diet exposure) of either SHU 0.1nmol (n=6 4th
v, n=6 3rd v) or vehicle (n=6 4th v, n=6 3rd v). This paradigm was altered to capture
possible immediate contribution of melancortin system to HF challenge based on results
of a recent publication (Voss-Andreae et al., 2007) in which MC-R blockade attenuated
brown adipose tissue activity induced by 48h HF diet exposure in mice. Food was
available ad libitum at all times during this paradigm, with the exception of day 2
(where animals were deprived only in the light cycle in order to obtain energetic
recordings without the possible confounding effects of food intake). Energy expenditure
parameters were measured from 0h-72h during the high fat diet exposure. Food intake
and body weight were measured at 24, 48 and 72h as illustrated in Figure 5.1C.

Statistical analysis:
Core temperature, HR and SPA were analyzed by ANOVA on post-injection 8 h average
values of each parameter and followed by student’s t-test or Tukey test as appropriate.
Twenty four hour food intake and body weight were analyzed by ANOVA and followed
by t-test or Tukey test as appropriate. Two way ANOVA was applied in experiment 1
(diet, drug) and three way ANOVA in experiment 2 (ventricle, drug, time), those were
followed up by 1-way ANOVAS or post-hoc tests as appropriate. All statistical analysis
was conducted using STATISTICA software (StatSoft, Inc., Tulsa, OK). Differences were
considered significant at P<0.05.
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RESULTS:
Experiment 1: Rats consumed 50% more kcal on the first 24h of MF exposure, during
the next 8 days MF consumption was increased by 20-30% on average as compared to
the chow control group (Figure 5.2A). There were trends to increase body weight staring
day 5 of MF exposure, however not significant (Figure 5.2B). Two-way ANOVA revealed
a significant diet-drug interaction for food intake (P<0.05) after 4th v. MC-R blockade.
Fourth v. MC-R blockade with 0.2nmol SHU did not significantly alter chow intake,
however intake in MF-fed rats was significantly increased (P< 0.005). All rats (MF-fed
rats and chow-fed controls) exhibited mild but significant hypothermia (P< 0.005) and
tachycardia (P< 0.0005) under SHU condition with no significant changes in activity in
response to SHU delivery to 4th v. There were no significant diet-drug interactions on
any of the energy expenditure parameters measured.

Experiment 2: A dose of MC-R antagonist without effect on any of the measured
parameters was desired for a elucidating a specific effect of MC-R blockade on rats
exposed to HF diet. SHU pretest on chow revealed that the 0.1nmol dose chosen for this
study had no significant effect on any of the parameters measured while the rats were
maintained on chow. After the rats were switched to HF diet however SHU application
significantly increased HF food intake. Three-way ANOVA (ventricle, drug, time)
revealed a significant effect of drug on food intake (P< 0.005) and no interaction of drug
with ventricle (Figures 5.4A&C). Three-way ANOVA also indicated a significant effect of
drug on body weight (P< 0.05) and no interaction of drug with ventricle (Figures
5.4B&D). There was no significant effect of drug and no significant drug-ventricle
interaction on any of the energy expenditure parameters in the dark cycle. (Figures
5.5&6). In the light cycle there was no significant effect of drug and no drug-ventricle
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interaction on heart rate or activity. High-fat fed rats that received SHU however had
significantly increased core temperature (p<0.05). There was no drug-ventricle
interaction.

DISCUSSION

Hindbrain MCR antagonism significantly decreased core temperature and heart
rate, suggesting that endogenous hindbrain MCR activity and “melanocortinergic tone”
contributes to the maintenance of body temperature and cardiovascular tone under
chow fed, baseline conditions. The bradycardia and reduced core temperature were also
induced by hindbrain MCR blockade in high-energy diet maintained rats, indicating that
the contribution of hindbrain MCRs to energy expenditure is not altered by high-fat
challenge. Diet maintenance was a factor in the feeding response to MCR antagonism
for hindbrain as well as forebrain ventricular delivery of SHU-9119. Rats maintained on
high-energy diets (either moderate or high-fat) were hyperphagic and gained weight in
response to MCR antagonism while chow-fed rats were unaffected. These results
suggest that increased endogenous melanocortinergic tone contributes to the
compensatory reduction of high-energy diet consumption in response to chronic diet
exposure.

Forebrain ventricular MCR antagonist treatment or MC4R knockout profoundly
disrupts endogenous melanocortin signaling under baseline, chow diet maintenance and
results in pronounced hyperphagia, hypothermia and decreased activity (Adage et al.,
2001; Butler et al., 2001). The global nature of these procedures makes it impossible to
distinguish between the contributions of anatomically distinct MCR populations to the
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measured responses. The current study is the first to selectively implicate hindbrain
MCRs in baseline energy expenditure maintenance by showing that hindbrain MCR
antagonism triggers a long-lasting hypothermia and bradycardia. These data
complement our experiments showing that agonist stimulation of hindbrain MCRs
triggers responses of the opposite valence - hyperthermia and tachycardia (Skibicka and
Grill, 2008a, 2009a).

As noted earlier MCR-bearing sympathetic pre-motor neurons are found in
several hindbrain nuclei whose activity contributes to thermogenic and cardiovascular
function (Skibicka and Grill, 2008a, 2009a). Additional experiments will be required to
define which of these hindbrain MCR bearing neurons contributed to the energetic and
cardiovascular effects observed here in response to 4th v antagonist delivery. It is likely
that differences between the inputs and outputs of a given structure might make its
contributions more relevant to the responses observed under chow maintenance than
for those observed in response to high-energy diet maintenance.

There are data that suggest that endogenous melanocortin signaling is affected
by diet macronutrient content but the direction of these effects varies across studies.
Stimulation and blockade of MCRs appears to selectively affect intake of diets high in fat,
rather then those with increased carbohydrate or protein content (Hagan et al., 2001;
Samama et al., 2003). Other experiments examine whether the anorexic or thermogenic
responses to MCR stimulation (via forebrain application of MC3/4 agonist – MTII or
αMSH) is affected by high-energy diet exposure. Results of those studies are highly
variable ranging from indications that feeding responses to MCR agonist are enhanced
(Hansen et al., 2001), unaltered (Li et al., 2004) or decreased (Clegg et al., 2003) in
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high-fat fed rats. In other studies it was observed that the decrease in food intake
induced by involuntary overfeeding of high-fat diet for 16 days was associated with an
increased expression of hypothalamic POMC mRNA (Hagan et al., 1999). This high-fat
induced decrease in intake is abolished by low dose 3rd v SHU application (Hagan et al.,
1999). The role of PVN MCR signaling on palatable liquid diet intake was highlighted by
results showing that PVN antagonist injection (agouti related protein; AgRP) potently
increased intake (Taylor et al., 2007). More recently PVN MCR adenoviral vector
knockdown increased high-fat intake without altering chow intake. Similar findings are
reported with chronic interference with MCR signaling in the lateral hypothalamus (Kas
et al., 2004). The current results with 3rd v SHU-9119 application are consistent with a
diet selective hyperphagic effect (present in high-fat and absent in chow fed rats).

These studies conclude that hypothalamic MCRs are the principal site of action
in mediating the observed effects. Not considered in those studies but the focus of the
current experiments is a determination of whether MCR expressing neurons in the
hindbrain contributes to the observed effects (Grill et al., 1998; Williams et al., 2000a;
Zheng et al., 2005; Skibicka and Grill, 2009a). Hindbrain SHU 9119 application (4th v
and direct NTS delivery ) induced a pronounced chow hyperphagia similar in size and
duration to that induced by forebrain drug application (Grill et al., 1998; Williams et al.,
2000a). The failure to consider a role for hindbrain MCR expressing nuclei in studies of
high-energy diet induced CNS changes may result from the prevailing view that
hindbrain circuits are relevant only to short-term feeding control (Cone, 2005). Current
data highlight the contribution of the hindbrain MCRs to the longer term consequences
of high-energy diet maintenance. The dose of the drug chosen in the current study was
not effective on baseline chow intake, but selectively affected moderate and high-fat
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intake. This is the first set of data showing an increased sensitivity to MCR blockade in
the hindbrain in rats fed a high-fat diet, as compared to those maintained on chow.
Several populations of neurons in the hindbrain express MCRs and contribute to food
intake. Two most prominent sites are the nucleus of the solitary tract and the
parabrachial nucleus (Williams et al., 2000a; Skibicka and Grill, 2009a). Both sites are
implicated in taste and palatability processing, whether blockade of MCR activity alters
the ability to sense the high caloric content of the diet, process the taste or perhaps
increases the palatability of the diet remains to be resolved.

The MCR antagonist used here targets both MCRs expressed in the brain – MC3
and MC4R. It is possible that for the 3rd v study blockade of both receptors contributes
to the hyperphagic response selective to high-energy diet fed rats. However the fact that
only MC4R, not MC3R knockout mice show and exacerbated hyperphagia and weight
gain on high-fat diets provides a counterpoint to a possible MC3R contribution (Butler
et al., 2000; Butler and Cone, 2002). Previous reports indicate that only expression of
MC4R and not MC3R is altered by exposure to energy-dense diets (Harrold et al., 1999).
Even a stronger case for a primary MC4R effect in the hindbrain can be made as several
reports indicate no MC3R expression in the hindbrain (Roselli-Rehfuss et al., 1993).

The current data indicate that moderate and high-fat diet exposure engages the
hypothalamic and hindbrain endogenous melanocortin system, what remains unknown
is what signals, induced by fat feeding, directly engage POMC neurons. Leptin and
insulin are peripheral circulating factors that increase with high-energy diet
maintenance, and activate POMC neurons to potentially mediate fat diet activation of
the central melanocortin system (Schwartz et al., 1997; Seeley et al., 1997; Satoh et al.,
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1998; Benoit et al., 2002; Rahmouni et al., 2003; Skibicka and Grill, 2009b).
Melanocortin receptor stimulation is the major downstream pathway within the CNS to
propagate leptin mediated anorexia as well as energy expenditure (Schwartz et al., 1997;
Seeley et al., 1997; Satoh et al., 1998; Skibicka and Grill, 2009b). Insulin-mediated
anorexia as well as sympatho-excitation utilizes the melanocortin pathway (Benoit et al.,
2002; Rahmouni et al., 2003). Since both leptin and insulin receptors are expressed on
ARC POMC neurons and can stimulate common intracellular signals it is also possible
that the integration of the two signals is required for POMC neuron activation. Relevant
to the hindbrain MCR selective high-energy intake response is that many of the
aforementioned signals also reach the hindbrain (NTS) POMC neurons. Hindbrain
POMC neurons are responsive to leptin treatment and blockade of hindbrain MCRs
abolishes the anorexic and energetic responses to hindbrain leptin stimulation. Insulin
receptors are also expressed in the hindbrain (Folli et al., 1994). Studies are needed to
resolve whether hindbrain leptin and/or insulin stimulation is upstream of the dietary
increase in activation of hindbrain MCRs. Another interesting possibility is that
leptinergic, insulinergic or other stimulation of hypothalamic POMC neurons and
subsequent projections to hindbrain MCR expressing populations leads to curbing of the
high-fat diet intake reported here.

No changes in thermogenesis and activity in rats challenged with moderate or
high fat diet were observed. Previous reports showed for e.g. increased oxygen
consumption after moderate-fat (25%) exposure already at the first 24h period in mice
(Butler et al., 2001), however the same group reports that BAT SNS activity was not
altered during that period, which would be consistent with lack of body temperature
changes in our study. It is therefore possible that other tissues then BAT are involved in

117

the SNS DIT response (like muscle) as oxygen consumption is a more global measure of
energy usage and reflects cumulative metabolic activity of all tissues. On the other hand
another report shows an increase in molecular activity of BAT (via UCP-1 mRNA
expression) in mice fed high fat (60%) diet (Voss-Andreae et al., 2007), which is
suggestive of BAT activation. However direct measurement of BAT temperature would
be necessary to assert translation of increased UCP-1 mRNA levels to increased
thermogenesis. In fact Li et al (Li et al., 2004) report increased UCP-1 levels in rats fed a
high-fat diet without any simultaneous changes in oxygen consumption. This could
reflect a potential disassociation of molecular and physiological parameters of energy
expenditure. Core body temperature is under tight central regulation. Therefore another
possibility might be that while BAT thermogenic activity might increase after high-fat
exposure, a change in core temperature is not seen as other counter-hyperthermic
measures are engaged by the organism in order to maintain the core temperature at a
constant level.

Together the findings presented here bring attention to the endogenous
contribution of the hindbrain MCRs to a variety of energetic parameters and feeding
responses. Future studies should resolve how this newly outlined contribution is
integrated into the current energy balance control model, to determine if it is integrated
with the hypothalamic circuitry or does it function independently and parallel to the
hypothalamus energy balance controlling circuits.
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Figure 5.1: Experimental paradigm utilized for measurements of food intake (FI), body
weight (BW), core temperature (TC), heart rate (HR) and spontaneous activity (SPA) in
experiment 1 (A); experimental days 4 and 7 of experiment 1 (B); in experiment 2 (C). Black bars
represent periods of lights out, white bars indicate lights on. Moderate fat (MF), high fat (HF),
ventricle (V).
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Figure 5.2: Enhanced hindbrain melanocortinergic tone after moderate-fat diet
exposure (experiment 1). A. Daily average caloric intake of chow and moderate-fat fed rats B.
Daily average body weight. Arrows represent 4th ventricle injection days. C. Hyperphagia and D.
body weight gain after hindbrain MCR blockade with 0.2nmol SHU 9119 are selective for
moderate-fat fed rats. Moderate fat (MF). * P<0.05
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Figure 5.3: Energetic effects of blockade of hindbrain MCRs with SHU 9119 on A.
core temperature B. Core temperature change relative to respective vehicle C. heart rate D.
spontaneous activity in rats fed chow (baseline conditions) and moderate fat food. Histograms
represent 8h average, with no food available during the period of energetic measurement.
Moderate fat (MF). * P<0.05
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Figure 5.4: Enhanced hindbrain melanocortinergic tone after high-fat diet
exposure – comparison of 3rd and 4th v studies. Hyperphagia and body weight gain
selective for high-fat fed rats after MCR blockade with 0.1nmol SHU 9119 in the forebrain (3rd
ventricle injection) A-B and hindbrain (4th ventricle injection) C-D. *P<0.05
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Figure 5.5: Energetic effects of blockade of hindbrain MCRs with daily 3rd
ventricular application of a sub-threshold (in control chow fed condition) dose of
SHU 9119 (0.1 nmol) in rats fed high-fat diet on A. core temperature B. heart rate C.
spontaneous activity in the light (left) and dark (right) cycle. Histograms represent 8h average,
with no food available during the period of energetic measurement.
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Figure 5.6: Energetic effects of blockade of hindbrain MCRs with daily 4th
ventricular application of a sub-threshold (in control chow fed condition) dose of
SHU 9119 (0.1 nmol) in rats fed high-fat diet on A. core temperature B. heart rate C.
spontaneous activity in the light (left) and dark (right) cycle. Histograms represent 8h average,
with no food available during the period of energetic measurement.
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CHAPTER 6
HINDBRAIN CART INDUCES HYPOTHERMIA MEDIATED BY GLP-1
RECEPTORS4

ABSTRACT

Cocaine- and amphetamine-regulated transcript peptides (CART) are widely distributed
throughout the neuraxis, including regions associated with energy balance. CART’s
classification as a catabolic neuropeptide is based on its inhibitory effects on feeding, coexpression with arcuate nucleus POMC neurons, and on limited analysis of its energy
expenditure effects. Here we investigate whether: 1) caudal brainstem delivery of CART
produces energetic, cardiovascular and glycemic effects, 2) forebrain – caudal brainstem
neural communication is required for those effects and 3) GLP-1 receptors (GLP-1R)
contribute to the mediation of CART-induced effects. Core temperature (Tc), heart rate
(HR), activity and blood glucose were measured in rats injected 4th v. with CART (0.1,
1.0 and 2.0µg). Food was withheld during physiologic recording and returned for
overnight measurement of intake and body weight. CART induced a long-lasting (> 6h);
hypothermia; a 1.5oC and 1.6oC drop in TC for the 1.0 and 2.0µg doses. Hindbrain CART
application reduced food intake and body weight and increased blood glucose levels; no
change in HR or activity was observed. Supracollicular decerebration eliminated the
hypothermic response observed in intact rats to hindbrain ventricular CART, suggesting
that forebrain processing is required for hypothermia. Pretreatment with the GLP-1R
antagonist (exendin-9-39) in control rats attenuated CART hypothermia and

4

These results were partially reported at the 2007 Obesity Society Meeting, in New Orleans, LA and
appeared in Journal of Neuroscience, 2009. This work was supported by NIH grants DK-21397 and NRSA
NS-059254
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hypophagia, indicating that GLP-1R activation contributes to hypothermic and
hypophagic effects of hindbrain CART while CART-induced hyperglycemia was not
altered by GLP-1R blockade. Data reveal a novel function of CART in temperature
regulation and open possibilities for future studies on the clinical potential of the
hypothermic effect.

INTRODUCTION

Cocaine-amphetamine-regulated transcript (CART) neuropeptides were
initially localized to the striatum and nucleus accumbens; regions associated with
reward, motivation and addiction (Douglass and Daoud, 1996). Later CART synthesis
was described in regions associated with energy balance control including the arcuate
and paraventricular hypothalamus, nucleus tractus solitarius (NTS) and vagal afferent
neurons (Koylu et al., 1997; Koylu et al., 1998; Broberger, 1999; Broberger et al., 1999;
Vrang et al., 1999b; Vrang et al., 1999a). In arcuate hypothalamic neurons, CART is coexpressed with proopiomelanocortin (POMC) whose cleavage product, α-MSH, is a
major catabolic contributor to energy balance (Butler and Cone, 2002; Cone, 2005).
Leptin up-regulates and food deprivation down-regulates hypothalamic expression of
both POMC and CART (Kristensen et al., 1998). Melanocortin receptor stimulation
produces hypophagia, hyperglycemia, hyperthermia, tachycardia and increased activity
(Fan et al., 2000; Gutierrez-Juarez et al., 2004; Skibicka and Grill, 2008a). Other
studies reveal that forebrain ventricular CART delivery decreases food intake and in
conjunction with the findings just described lead to the idea that CNS CART effects on
energy balance are catabolic in nature (Kristensen et al., 1998; Kuhar et al., 2000;
Rogge et al., 2008). The energy expenditure effects of CART are however, insufficiently
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investigated. The experiments reported here contribute to a developing perspective that
the functional effects of CNS CART signaling on energy balance are not consistent with a
catabolic role of CART55-102, as they revealed a hypothermic effect whose mediating
neural pathway is described.

Central CART administration (forebrain ventricle) suppresses and blockade of
CNS CART signaling with ventricular antiserum delivery increases food intake
(Kristensen et al., 1998). Direct hypothalamic CART administration, however, elicits
hyperphagia which contrasts with the hypophagia observed with ventricular delivery
(Abbott et al., 2001; Smith et al., 2008). This disparity between the direction of effect
for ventricular vs. direct hypothalamic CART administration suggests that the anorectic
action of CART is mediated by extra-hypothalamic sites. In fact, several studies show
that hindbrain ventricular (4th ventricle) delivery of CART produces anorexia (Aja et al.,
2001b; Zheng et al., 2001; Aja et al., 2002; Zheng et al., 2002).

While an indirect measure, the increases in brown adipose UCP-1 expression in
response to arcuate and paraventricular nucleus CART delivery (Wang et al., 2000;
Kong et al., 2003) indicates a role of hypothalamic CART in thermogenesis and
catabolic action. However, the energetic and cardiovascular effects of hindbrain CART
stimulation are largely unexplored (Hwang et al., 2004). CART is detected in several
hindbrain regions associated with energy balance/thermoregulation including NTS,
parabrachial nucleus (PBN), raphe pallidus, and rostral ventral lateral medulla (Dun et
al., 2000; Dun et al., 2001). For this reason our experiments examined the energetic
and cardiovascular effects produced by hindbrain (4th v. and NTS) CART55-102 delivery.
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Hindbrain glucagon-like peptide-1 receptors (GLP-1R) mediate CART55-102 induced hypophagia and neuronal activation (Fos-Li) observed in multiple hindbrain
sites (Aja et al., 2006). Some of these Fos-Li expressing nuclei are also relevant to
thermoregulation. Therefore our experiments also assessed whether hindbrain GLP-1R
contribute the energy expenditure effects of hindbrain CART55-102 stimulation.

METHODS

Subjects
Male Sprague Dawley rats (Charles River Laboratories, Wilmington, MA), weighing
300–400g (10-12 weeks old) at surgery and housed individually in plastic bins under a
12-h light, 12-h dark cycle (0800 h lights on), participated in the five experiments
described below. Pelleted food (Purina 5001; St. Louis, MO) and water were available ad
libitum unless otherwise noted. All procedures conformed to the institutional standards
of animal care and use committee (University of Pennsylvania).

Surgery
Rats were anesthetized with ketamine (90 mg/kg), xylazine (2.7 mg/kg), and
acepromazine (0.64 mg/kg) delivered im.

Fourth and third intracerebroventricular (v.) and NTS intraparenchymal
cannula implantation.
Rats in experiments 1, 3 and 4 received a fourth v. guide cannula (22 gauge; Plastics
One, Inc., Roanoke, VA) with its tip stereotaxically positioned 2.0 mm above the fourth
ventricle (coordinates: on the midline, 2.5-mm anterior to the occipital suture, and 4.5mm ventral to the dura, with injector aimed 6.5-mm ventral from dura). Rats in
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experiment 3 also underwent a decerebration surgery. Drug injections to the 4th v. at
volumes used in our experiments have been shown to be confined to the hindbrain
regions without stimulation of regions rostral to the 4th v. (Flynn and Grill, 1985; Blevins
et al., 2004; Fan et al., 2004; Hayes et al., 2008b). A second group of rats in experiment
4 received a third v. guide cannula (coordinates: on the midline, 2-mm posterior to
bregma, and 5.5-mm ventral to dura mater, with injector aimed 7.5-mm ventral to dura).
Rats in Experiment 5 received a cannula positioned 2.0-mm above the medial NTS
(coordinates: 0.5-mm from the midline, on occipital suture, 5.9-mm ventral to skull;
placement as we previously described in Hayes et al 2009). Cannulas were attached to
the skull with dental acrylic and jeweler’s screws, and closed with an obturator as
previously described (Fan et al., 2000; Gutierrez-Juarez et al., 2004; Skibicka and Grill,
2008a).

Decerebration surgery.
Supracollicular decerebration was performed in two hemi-transection stages separated
by at least 1 wk, as previously described (Grill and Norgren, 1978). Decerebrate rats
received 4th v. cannulas and telemetric transponders (described below) during the
second hemisection surgery. Pair-fed (gavage-fed) neurologically intact control rats were
also anesthetized on two occasions and implanted with fourth v. cannulas and telemetric
transponders during the second surgery. Rats recovered for at least 1 wk before the
experiment started. The completeness of the intended transection was verified
histologically after the experiment. Only rats with a histologically verified complete
transection were included in the data analyses.

Telemetric transponder surgery.
Telemetric transponders (HRC 4000 VitalView; Mini Mitter/Respironics, Bend, OR) for
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recording core temperature (TC), heart rate (HR), and spontaneous physical activity
(SPA) were inserted into the abdominal cavity, with the leads positioned sc and secured
to the chest muscles on either side of the heart with sutures.

Experimental procedures
Cannula position verification.
At least 7 d after surgery, all brain cannula placements were assessed by measurement of
the sympathoadrenal-mediated glycemic response to central injection of 5-thio-Dglucose [210 µg in 2 µl artificial cerebral spinal fluid (aCSF; Harvard Apparatus) for 3rd
and 4th v. and 21 µg in 0.1 µl for NTS] (Ritter et al., 1981). A post-injection elevation of at
least 100% of baseline plasma glucose level was required for subject inclusion.

Habituation training.
Before the start of experimental testing, rats were acclimated to the handling and
injection procedures used in a given experiment.

Food intake and body weight monitoring.
As described in Figure 6.1, food was removed at the time of injections (early in the light
cycle) and returned 8 h later, late in the light phase. Thus, food was not available during
the period of energetic/sympathetic response measurement. Food intake and body
weight measurements were made 24 h after the injection of drug. Given this design, all
noted differences in food intake reflect longer latency effects of CART (i.e. intake from
8–24 h after injection). For ad libitum-feeding rats, food was always available during the
dark cycle, and a minimum of 48 h was allotted between experimental testing for all
animals.
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Blood glucose response measurements: Blood glucose was measured before
ventricular injections and at 30, 60, 120 and 240 min post-injection by collecting a drop
of tail blood and placing it in a standard glucometer (Accucheck, Roche Diagnostics,
Indianapolis, IN). Food (chow) was not available during the blood glucose
measurements; it was returned immediately after the 240 min measurement and
measured 24h after drug injection.

Experiment 1
To determine the energy expenditure and food intake effects of hindbrain CART55-102
stimulation rats (n=23) received fourth v. vehicle injections (1 µl aCSF) counterbalanced
with one dose of CART (CART55-102, American Peptide Company, Inc., Sunnyvale, CA):
0.1 µg (19 pmol, n=4), 1.0 µg (190 pmol, n=9), 2.0 µg (380 pmol, n=10). CART55-102 was
chosen for this study as this peptide fragment has been previously shown to have
physiological effects when applied to the hindbrain (Aja et al., 2001b; Aja et al., 2001a;
Zheng et al., 2001; Aja et al., 2002; Zheng et al., 2002; Aja et al., 2006) and also effects
on thermogenesis when applied to PVN (Wang et al., 2000). Core temperature, HR and
SPA were recorded telemetrically for 1h before injections and 8h following injections
every 5 min (TC, SPA) or 30s (HR). Food intake and body weight were recorded 24h post
injections. To assess whether hindbrain CART induced effects on glycemia changes in
blood glucose were measured after 4th v. application of CART (2.0 µg) in a separate
group of rats (n=12).

Experiment 2
All rats (n=11) received 2.0 µg of CART or vehicle (saline) intraperitoneally (ip). The
purpose of this experiment was to test whether any of the effects of CART seen with the
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central treatment can be ascribed to diffusion of the peptide out of CNS and stimulation
of receptors in the periphery. Energy expenditure and food intake measurements were
made as described in Experiment 1.

Experiment 3
To begin to define the neurocircuitry mediating the energy expenditure effects of
hindbrain CART delivery the chronic decerebrate (CD) rat model was utilized. A lack of
effect in CD rats compared to intact controls would indicate the requirement for
forebrain neurocircuitry for mediation of a given effect. CD rats were maintained on a
liquid diet (AIN 76A rodent diet; Research Diets, New Brunswick, NJ; 9ml, gavage-fed 4
times daily) as they do not feed spontaneously. This maintenance regime provides 79
kcal/d and adequate hydration; rats gain weight on this regime. Feedings were separated
by intervals of at least 2 h. CD and gavage-fed intact control rats were maintained on this
feeding paradigm except during experimental testing when animals were only fed three
times: once 2 h before experiments commenced and twice after the experimental testing.
Core temperature of CD rats is more variable than that of control rats. Rectal
temperature was measured at each gavage feeding, and rats were cooled or heated if TC
was less than 34.0 or above 38.5ºC (except during experimental testing). Rats received
two doses of CART (1.0 and 2.0 µg) and vehicle in a counterbalanced design over three
separate testing days (separated by a minimum of 48 h). Core temperature, HR and
SPA were recorded telemetrically for 1h before injections and 8 h following injections.

Experiment 4
To determine whether the CART-induced changes in energy expenditure are mediated
by GLP-1Rs all rats (n=9: 3rd v, n=7: 4th v.) received four of the following ventricular
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injections counterbalanced over four testing days and separated by at least 48 h: 1) aCSF;
2) CART 1.0 µg; 3) CART 1.0 µg + Exendin-9 100 µg (Exendin 9-39, American Peptide
Company, Inc., Sunnyvale, CA); 4) Exendin-9 100 µg. Exendin-9 dose selection based
on (Aja et al., 2006). Core temperature, HR and SPA were recorded telemetrically for 1 h
before injections and 8 h following injections. To determine if the CART-induced
changes in blood glucose and food intake are mediated by GLP-1Rs, in a separate group
of rats (n=10), blood glucose levels, 24 h food intake and body weight change were
measured after 1) aCSF; 2) CART 2.0 µg; 3) CART 2.0 µg + Exendin-9 100 µg; 4)
Exendin-9 100 µg. Some effects of CART (e.g. gastric emptying) are mediated by
corticotrophin-releasing factor receptors (CRF-Rs) and not GLP-1Rs (Smedh and Moran,
2003) indicating that CART exerts it’s CNS action through at least two separable
neuropeptide pathways. To determine if the CART-induced changes in blood glucose
and food intake are mediated by CRF-Rs, in a separate group of rats (n=8), blood
glucose levels, were measured after 1) aCSF; 2) CART 2.0 µg; 3) CART 2.0 µg + CRF
antagonist 38 µg (α -helical CRF-(9-41); Sigma-Aldrich) 4) CRF -(9-41). CRF-(9-41)
dose selection was based on (Smedh and Moran, 2003). This dose was effective in
blocking CART induced inhibition of gastric emptying, it was also shown to have no
effects on CART hypophagia (Smedh and Moran, 2003).

Experiment 5
NTS is innervated by CART fibers and is also a site of thermoregulatory and intake
control(Koylu et al., 1997; Koylu et al., 1998; Broberger, 1999; Broberger et al., 1999;
Vrang et al., 1999b; Vrang et al., 1999a). To examine whether the NTS is the hindbrain
locus for the energy expenditure and food intake effects of CART observed following 4th
v. application all rats (n=12) received unilateral vehicle injections (0.1µl aCSF)

133

counterbalanced with one dose of CART: 0.1 µg into the parenchyma of the NTS. Energy
expenditure, food intake and body weight were recorded as in experiment 1.

Statistical analysis:
Core temperature, HR and SPA were analyzed by ANOVA on post-injection 6 h average
values of each parameter and followed by student’s t-test or Tukey test as appropriate.
Twenty four hour food intake and body weight were analyzed by ANOVA and followed
by t-test or Tukey test as appropriate. All statistical analysis was conducted using
STATISTICA software (StatSoft, Inc., Tulsa, OK). Differences were considered
significant at P<0.05.

RESULTS

Experiment 1
Core temperature: Fourth ventricular CART injections produced large and long-lasting
hypothermic responses, with an maximum drop of 0.7oC, 1.5oC and 1.6oC in TC and 6h
average effect size of -0.2ºC (P=0.902), -1.1ºC (P<0.0005), -1.3ºC (P<0.0005) for the
0.1, 1.0 and 2.0µg doses respectively (Figure 6.2a). Heart rate: Although heart rate
decreased slightly in some rats, this effect was not consistent across all rats and no
significant changes were noted for any of CART doses used (Figure 6.2b). Spontaneous
activity: No significant changes in spontaneous activity were observed (Figure 6.2c).
Blood glucose was significantly increased after 2µg CART injection at 30 (P<0.05), 60
(P<0.01) and 120 (P<0.05) minutes after injection, or as area under the curve (AUC;
P<0.05) (Figure 6.3a). Food intake was decreased by the 1.0 (P=0.058) and 2.0 µg
(P<0.05) CART doses (food available 8-24 h post injection), (Figure 6.3b). Body weight
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was also significantly decreased by the 1.0 (P<0.05) and 2.0µg (P<0.05) CART (Figure
6.3c).

Experiment 2
Peripheral application of CART had no effect on food intake, body weight and any of the
measured energy expenditure parameters (Figure 6.4).

Experiment 3
Gavage-fed control rats: Core temperature was significantly decreased by 4th v. CART
application at both the 1.0 (P<0.05) and 2.0 µg (P<0.0005) doses. CD rats: There was
no significant hypothermia noted after CART application in this group. (Figure 6.5). To
extract any possible short-term temperature effects that might have been present in the
CD rats, data were reanalyzed this set of data (on both CD and gavage-fed control rats)
by a two-way ANOVA looking at the interaction of time (30min periods) and drug. This
analysis yielded a significant effect of drug (p=0.005), time (p<0.0005), and a
significant interaction (p<0.0005) in gavage-controls. However there were no
significant effects in CDs [drug (p=0.41), time (p=0.20), and drug-time interaction
(p=0.74)].

Experiment 4
Significant hypothermia was noted when 1.0 µg of CART was applied alone in the 3rd
(P<0.05) or 4th v. (P<0.05). This CART-induced hypothermic response was abolished
following hindbrain-delivery of the GLP-1R antagonist Exendin-9 [100 µg; P=0.97 from
aCSF, Tc]. Exendin-9 application alone was without effect [3rd v: P=0.72; 4th v.: p=0.99;
Figure 6.6]. Consistently with results from Experiment 1 CART at 2.0 µg produced a
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significant hyperglycemic response when delivered to the 4th v. (P<0.005); this effect
was not altered by the Exendin-9 treatment (P<0.005 from aCSF). Fourth ventricular
CART delivery (2.0 µg) significantly reduced chow intake (P<0.001); pretreatment with
the GLP-1R antagonist attenuated this effect (P=0.21 from aCSF). Similarly the
reduction in 24 h body weight produced by CART 4th v. (P<0.005) was attenuated by
Exendin-9 pretreatment (P=0.69; Figure 6.7 a-d). In a separate group of rats the effect
of CRF-R blockade on CART induced hyperglycemia was evaluated. CART at 2.0 µg
produced a significant hyperglycemic response when delivered to the 4th v (P<0.01); this
effect was not altered by the CRF-(9-41) treatment (P<0.05 from vehicle; Figure 6.7e-f).
There was no effect of the CRF-(9-41) alone (P=0.99 from aCSF).

Experiment 5
Intraparenchymal injection of CART at a dose that was ineffective when applied in the
4th v. (0.1µg) significantly (P<0.05) decreased TC when applied to the medial NTS
parenchyma (Figure 6.8a). Only rats with confirmed NTS placement were included in
the data analysis (representative injection site is shown in Figure 6.8b). No significant
changes were observed in HR, SPA, food intake, and body weight.

DISCUSSION

Our experiments addressed the hypothesis that CART peptide’s effects on energy
balance cannot be characterized as simply catabolic in nature. CART peptide was
applied to the 4th ventricle (hindbrain-directed), the 3rd ventricle (hypothalamusdirected), and directly to the NTS parenchyma and its effects on energetic (TC and
activity), cardiovascular (HR), food intake, body weight, and plasma glucose parameters
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were measured. Our data show that CNS delivery of CART results in a hypothermia. We
discuss the hypothermic effect first, the GLP-1R mediation of this response next, and
then review the other effects observed.

These are the first data to show that hindbrain CART55-102 delivery induced a
pronounced and long-lasting hypothermic response (a 1.5oC and 1.6oC decrease in TC for
the 1.0 and 2.0 µg doses relative to vehicle treatment; >6h duration). Injections of CART
into the forebrain ventricle (providing access of drug to forebrain and hindbrain sites
due to the caudal flow of CSF), hindbrain ventricle, and hindbrain parenchyma (intraNTS) were each effective in decreasing TC. The potent and long duration of hypothermia
triggered by injections selective to the hindbrain ventricle or NTS parenchyma, that
bypass forebrain, indicated that CART responsive neurons located within the hindbrain
and at least partially within the NTS mediated the hypothermic response. Additional
experiments evaluating hypothalamic or forebrain parenchymal sites are needed to
directly exclude the possibility of forebrain contribution to the hypothermic response.
However, the few published studies that examine the energy expenditure effect of
hypothalamic (ARC; PVN) CART injection show responses (increases in brown adipose
tissue (BAT) UCP-1) that are typically associated with a hyperthermic action (Wang et
al., 2000; Kong et al., 2003). That the thermic response to hypothalamic CART injection
is opposite in direction to the current findings strengthens the hypothesis that the
hypothermia was mediated by hindbrain CART responsive neurons.

We recently showed (Hayes et al., 2008a) that stimulation of hindbrain GLP-1R
induces hypothermia similar in duration and size to that produced by CART in the
present study. Current data establish that GLP-1 neurons and hindbrain GLP-1Rs are
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downstream mediators of the effect of CART55-102 on Tc as the hypothermic effect of
CART was eliminated by blockade of hindbrain GLP-1Rs with Exendin 9-39. It is
interesting to note that the hypothermic effect of hindbrain GLP-1R stimulation does
not require intact forebrain-hindbrain communication as the effect was unaltered by
supracollicular decerebration (Hayes et al., 2008a). By contrast, we showed here that
the hypothermic effect of CART requires neural connections between the forebrain and
hindbrain and forebrain processing is required, as the hypothermia was not present in
rats with chronic supracollicular transsection. Therefore the circuitry mediating the
hypothermic effect of CART might involve hindbrain neurons responsive to CART that
project to the forebrain. The identity of those forebrain-projecting neurons is not known,
however our data showing hypothermia in response to NTS CART stimulation suggests
that at least part of CART’s effects on temperature is mediated by potential CART
receptors located in or near the NTS. NTS neurons project heavily in a rostral fashion
(e.g. PBN) to nuclei that relay peripheral thermal information to thermoregulatory
neurons in the hypothalamic preoptic area (Nakamura and Morrison, 2008). The
forebrain-relayed information would be subsequently transmitted back to the hindbrain
resulting in putative GLP-1 release from the NTS proglucagon expressing neurons and
subsequent hindbrain GLP-1R stimulation. Once activated, the output pathway
following hindbrain GLP-1R activation inducing hypothermia is contained within the
hindbrain (Hayes et al., 2008a). Several nuclei expressing GLP-1Rs within the hindbrain
contain sympathetic premotor neurons (Yamamoto et al., 2002). It is possible that
inhibition of those neurons results in the observed hypothermia. Experiments
evaluating hindbrain CART and GLP-1 effects on SNS neurons and BAT activity are
needed to evaluate this possibility. Another potential mechanism contributing to
hypothermia is SNS-mediated vasodilatation. A role of other neurotransmitters (e.g.
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serotonin and dopamine) that are associated with hypothermic responses (Cryan et al.,
2000; Catalina et al., 2002) in this pathway is possible and remains to be investigated.

While the hypothermic response to hindbrain CART55-102 peptide stimulation
contrasts with the hyperthermic effect of hindbrain melanocortin receptor stimulation,
the anorexia and acute hyperglycemic effects of CART injection are similar to those
observed with melanocortin delivery (Fan et al., 2000). The anorexic effect of hindbrain
CART stimulation observed here is consistent with several studies (Kristensen et al.,
1998; Rogge et al., 2008). Furthermore, Aja et al. (Aja et al., 2006) show that GLP-1Rs
are downstream of the anorexia triggered by hindbrain CART as measured by
alterations in palatable diet (Ensure®) intake. Our studies confirm this GLP-1R
mediation of anorexic effects of CART and extend the conclusion to effects on
consumption of standard chow (food of lesser palatability). We show, for the first time,
that acute CART55-102 stimulation increased blood glucose levels. This is consistent with
the direction of acute effect of CNS melanocortin stimulation on blood glucose (Fan et
al., 2000). Unlike CART’s hypothermic and anorexic effect, the hyperglycemic effect was
not mediated by hindbrain GLP-1Rs as blockade of hindbrain GLP-1Rs did not alter
CART-induced hyperglycemia. Other effects of CART (e.g. gastric emptying) are
mediated by CRF-Rs (Smedh and Moran, 2003), but not GLP-1Rs. Here we show that
CART-induced hyperglycemia does not require hindbrain CRF-R mediation, indicating
that a different mechanism might govern the hyperglycemic effect of CART.

CART peptides are not only widely present in the CNS but also detected in some
areas relevant to energy balance outside of the CNS including the adrenal medulla, gut,
and pancreas (Thim et al., 1998; Jensen et al., 1999; Thim et al., 1999). In order to
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evaluate the potential contribution of CART stimulation outside of the CNS to energetic
and anorexic effects of CART rats were injected ip with the highest dose of CART applied
in the ventricle. Peripheral CART55-102 application did not have any effects on any of the
measured parameters, suggesting that effects seen after central CART application do not
result from stimulation of potential receptors accessed by ip injection.

Our current data, along with those of others [see (Kuhar et al., 2000) for review],
suggest that CNS CART peptide plays a role in several anatomically separable circuits.
CART stimulation within the cortical and mesolimbic regions elicits reward and
motivation responses (Jaworski and Jones, 2006). CART stimulation in the mesolimbic
nucleus accumbens produces anorexia (Yang et al., 2005). Hypothalamic CART
injection has varied effects on food intake, but appears to increase energy expenditure
(UCP1 activity) (Wang et al., 2000; Kong et al., 2003). In hypothalamic explants CART
suppresses release of MSH and induces agouti-related protein release. In addition, while
CART and POMC are co-expressed in arcuate hypothalamus, CART is also co-expressed
with the orexigenic peptide melanin-concentrating hormone in lateral hypothalamic
neurons (Broberger, 1999). Hindbrain CART application decreases food intake, gastric
emptying (Smedh and Moran, 2003), and as shown here core body temperature.
Further evaluation of the complexity of CART’s functional effects and the mediating
neurocircuitry awaits the discovery of CART receptors.

The observed hypothermia was not associated with other anabolic indicators.
Our measurements included several parameters that are associated with energy
expenditure and sympathetic control (TC, activity, HR). Melanocortin treatment for
example alters all three parameters in the catabolic direction consistent with increased
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energy expenditure and sympathetic activation (Fan et al., 2000; Gutierrez-Juarez et al.,
2004; Skibicka and Grill, 2008a) . CART injection triggered a different pattern of
response – hypothermia without alteration in activity and HR. If CART hypothermia is
not a part of a coordinated pattern of energy balance effects, then what is the
physiological utility of potent and sustained hypothermic response? Several processes
have been associated with a marked hypothermia. Conditioned taste aversion (CTA) is
often accompanied by a hypothermic response. Some studies (Aja et al., 2002) suggest
that CART plays a role in CTA response. LiCl, a common inducer of CTAs, produces
hypothermia via α1-adrenergic receptor (Amaro et al., 1996). It has been proposed that
hypothermia might enhance CTA formation by extending the associative interval
between presentation of taste conditioned stimuli and the unconditioned aversive
effects of LiCl or other agents (Hinderliter et al., 2002; Hinderliter et al., 2004).
Therefore the elicited CART hypothermia might be adaptive in facilitating CTA
formation. Another process enhanced by hypothermia is neuroprotection (Sahuquillo
and Vilalta, 2007). Neuronal survival after conditions of decreased oxygen supply (e.g.
ischemia) is often increased if core temperature is decreased after the ischemic episode;
this phenomenon is observed in rat models of ischemia and is utilized as a treatment
strategy in ischemic patients (see (Hoesch and Geocadin, 2007) and (Nagel et al., 2008)
for review). CART is associated with a neuroprotective effect in ischemia (Xu et al.,
2006; Jia et al., 2008). Induction of hypothermia could be a part of the mechanism by
which CART exerts a neuroprotective effect. Other experiments are needed to evaluate
this hypothesis and whether the CART-induced hypothermia is physiological in nature.
Our results indicate that the hypothermia induced by CART is long lasting and shows
little tolerance upon repeated exposure (data not shown), two properties highly sought
after in potential hypothermia-inducing neuroprotective treatments.
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Figure 6.1: Experimental paradigm utilized for measurements of core temperature
(Tc), heart rate (HR), spontaneous activity (SPA) and food intake.
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Figure 6.2: Effect of hindbrain CART stimulation (4th v. injection) on (a) core
temperature (Tc), (b) heart rate (HR) and (c) spontaneous activity (SPA). Line graphs represent
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across-rat average parameter measurements through the 8h recording period. The bracketed
time period on the line graph x-axis indicates the periods used in the histograms. The histograms
provide 6h post-injection averages + SEM for each parameter at each dose. *P < 0.05 from
vehicle.
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Figure 6.3: Effect of hindbrain CART stimulation (4th v. injection) on (a) blood
glucose levels (b) 24h food intake (c) 24h body weight. The histograms provide averages + SEM
for each parameter at each dose. *P < 0.05 from vehicle.
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Figure 6.4: Effect of peripheral CART stimulation (ip delivery) on (a) core temperature,
(b) heart rate and (c) spontaneous activity (d) 24h food intake (e) 24h body weight. The
histograms provide averages + SEM.
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Figure 6.5: Effect of hindbrain CART stimulation (4th v. injection) on core temperature
(Tc) in (a) chronic decerebrate and (b) gavage-fed rats. Line graphs represent across-rat
average parameter measurements through the 8h recording period. The histograms provide 6h
post-injection averages + SEM for each parameter at each dose. *P < 0.05 from respective vehicle.
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Figure 6.6: Effect of GLP-1R blockade by Exendin 9-39 (100 µg) on the CARTinduced (1 µg) hypothermia with drugs delivered to the (a) 4th v. (b) 3rd v. Line
graphs represent across-rat average parameter measurements through the 8h recording period.
The histograms provide 6h post-injection averages + SEM for each parameter at each dose. *P <
0.05 from vehicle.
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Figure 6.7: Effect of GLP-1R blockade by Exendin 9-39 (100 µg) on 4th v. 2 µg CARTinduced (a-b) hyperglycemia (c) hypophagia (d) 24h body weight, (e-f) effect of CRF
receptor blockade by (CRF ant; 38 µg of α -helical CRF-(9-41)) on 4th v. CART
induced hyperglycemia. The histograms provide post-injection averages + SEM. Area under
the curve (AUC) *P < 0.05 from vehicle.
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Figure 6.8: Effect NTS delivery of CART on core temperature (TC). (a) line graph
represents across-rat average parameter measurements through the 8h recording period. The
bracket outlines 6h post-injection period. *P < 0.05 from vehicle. (b) representative NTS
injection site (indicated by the arrow). 4V: 4th ventricle, Sol: nucleus of the solitary tract, SolM:
medial nucleus of the solitary tract, SolIM: intermedial nucleus of the solitary tract, SolCe:
central nucleus of the solitary tract.
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CHAPTER 7
GENERAL CONCLUSIONS
DRUG

MTII
(Ch.
2&3)

SHU
9119
(Ch. 5)

Leptin
(Ch. 4)

CART
(Ch. 6)

GLP-1
(Ch. 6)

SITE OF
APPLIC
ATION

PHYSIOLOGICAL EFFECT

CHRONIC
DECEREBRATE
EFFECT

TC

HR

SPA

FI

BW

4th v

↑

↑

↔

↓

↓

TC↑,HR↑, SPA↑,
(FI N/A)

RVLM
PBN
RCh
RAPHE
NTS
PVN
AHA
4th v

↑
↑
↑
↑
↑
↑
↔
↓

↑
↑
↑
↑
↑
↑
↔
↓

↔
↔
↔
↑#
↑
↑
↔
↔

↓#
↓
↓
↓#
↓
↓
↔
↑

↓#
↓
↓
↔
↓
↓
↔
↑

N/A

N/A

4th v

↑

↑

↔

↓

↓

N/A

NTS
PBN
3rd v
4th v

↑
↔
↓
↓

↑#
↔
↔
↔

↔
↑
↔
↔

↓
↓
↓
↓

↓
↓
↓
↓

NTS
4th v

↓
↓

↔
↑

↔
↔

↔
↓

↔
↓

INTERACTIONS

 All effects blocked
by MC3/4R antagonist
(SHU 9119)

TBAT↑ as in intact

N/A
(TC,HR, SPA)↔
(FI N/A)

 TC and HR not
altered by HF feeding,
but increased FI & BW
effect, suggesting
enhanced hindbrain
MSH tone with HF
exposure
 4th v leptin TC,HR,
FI & BW effects
mediated by hindbrain
MCRs as 4th v SHU
9119 attenuates those
effects
 All 4th v effects not
altered by high-fat diet
feeding

 TC , FI & BW
effects mediated by
hindbrain GLP-1Rs
( their blockade
attenuates 4th v CART
effects)

N/A
TC↑↓,HR↑, SPA↓,
FI↓

Table 7.1: Summary of collected data. ↑ - increase, ↓ decrease, ↔ - no change in a measured
parameter, # - weak effect (borderline significant or non consistent between experiments), N/A –
not applicable, Ch - chapter. For a list of abbreviations please refer to appendix 1.

151

The experiments described in this dissertation challenge the hypothalamus centered
focus on energy balance control that dominates the literature and instead make clear
that CNS control of energy balance is broadly distributed across the neuraxis. Strong
support is provided for a critical contribution of hindbrain melanocortin and leptin
signaling to energy balance control. The role of the hindbrain neural processing to
energy balance regulation is highlighted in several complementary ways. Results
presented in Chapter 2 clearly indicate that feeding, energetic and cardiovascular
responses can be obtained by hindbrain melanocortin receptor (MCR) stimulation.
Further, caudal brainstem processing was found to be sufficient for mediation of the
energetic and cardiovascular responses, as the same direction and duration of effects
were observed in a chronic decerebrate rat model as those produced in a neurologically
intact rat. These findings indicate that the mediating circuitry, that engages sympathetic
outputs following hindbrain MCR stimulation, is contained entirely within the
hindbrain. These are the first data to demonstrate the sufficiency of hindbrain MCR in
initiating energy expenditure responses. Chapter 3 introduced another level of
anatomical analysis outlining the individual energy balance response profiles from
several discrete hindbrain MCR-expressing populations. Here, the role of several
hypothalamic nuclei is also investigated, highlighting the fact that the goal of the work
was not to shift the energy balance control model to the hindbrain but to create a
balanced, anatomically distributed perspective. Data presented in Chapter 4 are
consistent with the presence of a hindbrain specific leptin-melanocortin circuit, possibly
parallel to the one that has been well established in the forebrain. The data presented
herein have begun to approach the issue of inputs integrated by the hindbrain MCR
population. This concept was advanced in Chapter 5, where endogenous hindbrain MCR
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activity was shown to be necessary for the adaptive feeding responses elicited by chronic
ingestion of a high-fat maintenance diet. Chapter 6 provides data on hindbrain-directed
cocaine and amphetamine related transcript (CART)-mediated energy balance effects.
Due to coexpression of CART peptide with the proopiomelanocortin (POMC) peptide in
the hypothalamic POMC neuron population, the functional effects of CART on energy
balance have been often linked to those of melanocortins. This idea was strengthened by
the fact that both hypothalamic and hindbrain CART stimulation, similarly to MCRs
stimulation, resulted in anorexia (Kristensen et al., 1998; Zheng et al., 2002). Here
however, we show that unlike the hyperthermic effect of CART in the hypothalamus,
application of CART to the hindbrain produces a large and sustained hypothermia.
These data thus provide caution to general characterizations of neuropeptide effects in
the hypothalamus to the hindbrain and emphasize the need for direct hindbrain testing.

With respect to the melanocortin system, our studies clearly provide support for
an independent role of hindbrain MCRs in mediating energy balance effects,
independent of neural communication with the forebrain. Those data speak to a
hindbrain location of receptors and downstream mediating pathways for the
melanocortinergic effects on energy balance. Future studies are needed to identify the
endogenous source of hindbrain MCR activation that accounts for the energy balance
effects observed here by exogenous hindbrain MCR ligand application. To affirm a
completely independent hindbrain circuit two more questions, pertaining to events
upstream of MCR activation, should be answered: 1) a source for endogenous ligand for
the hindbrain MCRs would have to be located in the hindbrain (NTS POMC
populations), and 2) this source would have to be driven by hindbrain selective inputs.
In the simplest form, there could be two parallel independent circuits, one in the
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forebrain and the other in the hindbrain. The first circuit would consist of a forebrain
loop: peripheral inputs directly stimulating ARC POMC neurons that project to
hypothalamic/forebrain MCR expressing nuclei that subsequently engage the
sympathetic and anorexic output (by direct projections to spinal cords IML, or through
hindbrain relays); and a hindbrain loop with peripheral inputs directly stimulating NTS
POMC neurons projecting to hindbrain MCR expressing areas leading to sympathetic
and anorexic action. This simplistic model however, was already challenged by several
publications indicating that ARC POMC neurons send their projections caudally to the
midline hindbrain MCR expressing nuclei, in addition to their multiple forebrain
projections. In fact we have recently showed (in collaboration with HR Berthoud;
Berthoud HR et al., 2008) that nearly 70% of MSH fibers in the NTS are of
hypothalamic origin. Thus, NTS POMC neuron projections are likely a minority in the
midline hindbrain nuclei, however they may play a major role in stimulation of the more
laterally distributed MCR populations in the hindbrain like the RVLM (Sim, 1994). An
additional level of hindbrain-forebrain melanocortin interaction is added by the fact
that some nuclei, such as the PBN, are likely innervated by both POMC sources (Joseph
and Michael, 1988; Sim, 1994) and indicate that in addition to two simple, parallel and
separable forebrain and hindbrain circuits there are other MCR-driven circuits that
contain necessary elements in both forebrain and hindbrain regions.

Inputs to the melanocortin agonist-producing POMC neurons from peripheral
signals, conveying information about the metabolic status, are a fundamental element in
the current model of CNS energy balance control. As is the case for existing MCR
literature, here too the focus has mostly been on the inputs to the hypothalamic ARC
POMC neurons. Data presented here (Chapters 2 and 3), however, clearly support the
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need to extend the evaluation of inputs to the hindbrain NTS POMC populations.
Studies in Chapters 4 and 5 have partly begun to evaluate the sources of inputs to the
two CNS POMC populations. The hindbrain leptin-melanocortin study presented in
Chapter 4 is highly suggestive of an independent hindbrain circuit, as both the input
(hindbrain-directed leptin effects) and the output (MCR stimulation and downstream
energetic effects) required to elicit a thermic and anorexic responses are located within
hindbrain nuclei. To place this circuitry entirely within the hindbrain one more link, one
from leptin receptor activation to NTS POMC activation, has to be characterized and
localized to the hindbrain. Final confirmation of a circuit endemic to the hindbrain,
bypassing any forebrain projection would be indicated if the same hindbrain leptinmelanocortin interaction was shown in a chronic decerebrate rat, where all neural
forebrain-hindbrain connections are severed. This would indicate that all necessary
components from receptors of peripheral inputs, through integratory components to
output are contained in a forebrain-independent, hindbrain circuit.

Leptin is just one of many inputs potentially activating POMC neurons, resulting
in release of the MSH ligand and activation of MCRs. It is still unclear which
physiological or pathophysiological factors regulate the activity of the ARC and NTS
POMC populations, and whether these populations are activated / inhibited together or
separately. In the work presented here, we focus on view of brain organization that can
be called distributed control in different contexts (high-fat diet, leptin) under which
thermogenic, cardiovascular and feeding responses could be observed. At both
hindbrain and forebrain, MCR signaling is involved in generation of feeding responses
to these presented challenges. The location of POMC neurons required for this feeding
response remains an open question. Interestingly the energetic effects of melanocortins
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were not altered under high-fat conditions, indicating perhaps that some inputs (here
arising from high-fat diet maintenance) regulate the feeding and energetic effects of
melanocortins differentially.

In future studies it will be important to incorporate different testing paradigms,
as the mediating substrates, and pathways that ultimately converge on sympathetic and
feeding control centers, are likely to vary to some extent given different sensory
components (e.g. diet vs. cold vs. systemic pathogen introduction). Fever, for example,
is a centrally mediated response that can be induced by a systemic infection with bloodborne pathogens like bacteria (Saper, 1998; Zhang et al., 2000). Peripheral
administration of lipopolysacharide (LPS), a piece of gram-negative bacterial cell wall
that induces an immune system response, is a common model for infection-induced
fever. Although during a fever, core temperature increases above its normally tolerated
range, the response is arguably under feedback control; i.e. the temperature set range is
increased. Brown adipose tissue (BAT) in rodents is the primary effector contributing to
fever (Cannon and Nedergaard, 2004). CNS pathways involved in the thermogenic
response to LPS have been partially elucidated by immunohistological analysis (Foslike-immunoreactivity). Areas of CNS showing c-Fos induction include brainstem
regions, such as the NTS and VLM, as well as hypothalamic regions, such as the PVN
and MPOA (Zhang et al., 2000). Interestingly, melanocortin neurons and their
receptors are found in these structures.

Like all homeothermic animals, rats apply thermoregulatory mechanisms to
defend body temperature in response to challenging ambient temperatures. Thus,
adaptive thermogenic responses are reliably driven by cold temperatures. In rodents,
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shivering thermogenesis is recruited first. Melanocortin contribution to acute cold
thermogenesis in MCR knock-out mice has been recently indicated (Voss-Andreae et al.,
2007). We explicitly addressed the potential MC contribution to cold thermogenesis, at
forebrain and hindbrain levels of the neuraxis, but were not able to show any significant
effects of MCR blockade on maintenance of body temperature in the cold. While these
data might suggest that MCR system is not essential for cold and fever responses in a rat
(contrary to what has been shown in a mouse), they do not rule out contribution of this
system to those responses. Several factors might have contributed here to mask the
MCR contribution, considering the redundancy in the control of thermogenesis in those
complex responses. The environment and energy state of the rats before the experiment
could interact to bypass the requirement for MCR activation during our studies. This
idea has been evaluated recently in mice that lack UCP-1, an uncoupling protein utilized
in BAT to generate heat (Feldmann et al., 2009). Initial studies of diet-inducedthermogenesis in these UCP-1 KO mice have not been successful at showing any
thermogenic dysfunction. However, a careful follow-up study has uncovered their deficit
in mustering diet-induced thermogenesis but only when these mice were maintained at
thermoneutrality (without thermal stress) (Feldmann et al., 2009). The constant
thermal stress likely engaged other thermoregulatory mechanisms, which were then
easily utilized for diet-induced thermogenesis despite the lack of UCP-1. Those findings
underscore the importance of careful consideration of all environmental variables when
conducting thermic studies. It is important to note that most experiments are conducted
at a “room temperature”, comfortable for the experimenter, however several degrees
below the rodent thermoneutral zone. It is entirely possible that alterations in the
maintenance temperature also influenced the outcome of our above mentioned studies
evaluating the MCR contribution to cold induced thermogenesis. Thus negative data
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obtained may not be entirely conclusive and further studies availing of different
paradigms are warranted.

The lack of effect of acute pharmacological studies in the non-feeding focused
paradigms described above along with the strong nutritional/metabolic status
component of the so far characterized inputs to the melanocortin system leads to
another important question: do the melanocortin/leptin peptides play a primary role in
non-feeding induced thermogenesis (cold, pathogen etc.), or do they play a permissive
role, integrating the energy status into an equation requiring loss/usage of energy? The
first would be supported if evidence of direct influence of signals associated with each of
those challenges reaching POMC neurons (e.g. PGE or IL receptors) was found directly
on POMC neurons. Even under this situation, their activity could be gated by other
input they receive. Such input raising PGE2 levels should increase activity of POMC
neurons leading to increased thermogenesis. This increase in POMC activity could be
tampered by a simultaneous drop in leptin signaling, indicating insufficient energy
stores resulting in a lower fever then one that would have been permitted in conditions
of sufficient energy stores. Conversely, if leptin or other input to POMC neurons would
signal excessive energy stores, it is possible that fever could be larger. Consistent with
this hypothesis is the fact that obese rats have exaggerated fever and anorexia responses
to interleukin 1b (Plata-Salaman et al., 1998).

Based on the weight of evidence presented here, it is clear that both the
melanocortin system and its leptinergic inputs controlling for energy balance regulation
are anatomically distributed within the CNS. What is the utility of this distributed model?
Stimulation of either the NTS or ARC POMC neuron populations can lead to
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simultaneous release of ligand onto many neuroanatomically divergent MCR
populations, which may again converge, to induce similar output responses. This
divergence might on the surface seem redundant, since final output parameters are
likely similar, however one advantage of this system design is the gained ability of the
output to be modulated on many levels. Each nucleus in which MCR expressing neurons
are stimulated presumably receives many other unique inputs. Each of these separate
MCR-expressing neurons now has the ability to modulate the final energetic outcome
response. Therefore, the final outcome can now be finely modulated, filtered and
integrated with other available energy status information that is being communicated to
the CNS through the neuroendocrine system. Thus, the putative simultaneous release of
neuronal ligands onto various brain regions could allow for fast and effective influence
on many circuits instantaneously.
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Appendix 1.
List of commonly used abbreviations:
5-TG – 5 thio-glucose
aCSF – artificial cerebrospinal fluid
AgRP – Agouti related protein
AHA – anterior hypothalamic area
ARC – arcuate nucleus of the hypothalamus
BAT – brown adipose tissue
BW – body weight
CART – cocaine and amphetamine related transcript
CD – chronic decerebrate
CNS – central nervous system
CSF – cerebrospinal fluid
EE – energy expenditure
FI – food intake
GLP-1 – glucagon like peptide 1
HF – high fat
HR – heart rate
I.C.V. - intracerebroventricular
IML – interomedial lateral column of the spinal cord
LPS – lipopolysacharide (a piece of gram negative bacterial cell wall)
MCR – melanocortin receptor
MF – moderate fat
MPOA – medial preoptic area of the hypothalamus
MSH – melanocyte stimulating hormone, an MCR agonist
MTII – melanotan II (exogenous MC3/4R agonist)
NTS – nucleus of the solitary tract
Ob-Rb – leptin receptors
POMC – proopiomelanocortin (a precursor for MSH)
PBN – parabrachial nucleus
PVN – paraventricular nucleus of the hypothalamus
RPa – raphe pallidus
RVLM – rostroventral medulla
RCh – retrochiasmatic area of the hypothalamus
SHU 9119 – and exogenous MC3/4R antagonist

160

SPA – spontaneous activity
Tc – core temperature
UCP-1 – uncoupling protein 1
V. - ventricular
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